

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Updates in rare and not-so-rare complications of... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-791/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-791" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly" />
    
            <meta name="og:title" content="F1000Research Article: Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly.">
            <meta name="og:description" content="Read the latest article version by Fabienne Langlois, Gabriela M. Suarez, Maria Fleseriu, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="25044">
            <meta name="article-id" content="22683">
            <meta name="dc.title" content="Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly">
            <meta name="dc.description" content="Acromegaly is a complex disease with excessive growth hormone and insulin-like growth factor 1 (IGF-1) causing multisystem effects, particularly cardiovascular, respiratory, and metabolic. Psychological concerns and poor quality of life (QoL) are also major disease consequences. This review is intended for clinicians and focuses on the latest developments related to respiratory and QoL effects of long-term growth hormone excess. Along with biochemical disease control, patient treatment satisfaction and outcomes have become major treatment objectives; current knowledge and tools to evaluate and manage this aspect of the disease are described. Sleep apnea syndrome and other derangements of lung function and apparatus, from pathophysiology to treatment, and evaluation tools and determinants of QoL in patients with acromegaly are discussed.">
            <meta name="dc.subject" content="Acromegaly, growth hormone excess, respiratory complication, sleep apnea, quality of life, patients reported outcome">
            <meta name="dc.creator" content="Langlois, Fabienne">
            <meta name="dc.creator" content="Suarez, Gabriela M.">
            <meta name="dc.creator" content="Fleseriu, Maria">
            <meta name="dc.date" content="2020/07/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.22683.1">
            <meta name="dc.source" content="F1000Research 2020 9:791">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Acromegaly">
            <meta name="prism.keyword" content="growth hormone excess">
            <meta name="prism.keyword" content="respiratory complication">
            <meta name="prism.keyword" content="sleep apnea">
            <meta name="prism.keyword" content="quality of life">
            <meta name="prism.keyword" content="patients reported outcome">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/07/29">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="791">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.22683.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-791">
            <meta name="citation_title" content="Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly">
            <meta name="citation_abstract" content="Acromegaly is a complex disease with excessive growth hormone and insulin-like growth factor 1 (IGF-1) causing multisystem effects, particularly cardiovascular, respiratory, and metabolic. Psychological concerns and poor quality of life (QoL) are also major disease consequences. This review is intended for clinicians and focuses on the latest developments related to respiratory and QoL effects of long-term growth hormone excess. Along with biochemical disease control, patient treatment satisfaction and outcomes have become major treatment objectives; current knowledge and tools to evaluate and manage this aspect of the disease are described. Sleep apnea syndrome and other derangements of lung function and apparatus, from pathophysiology to treatment, and evaluation tools and determinants of QoL in patients with acromegaly are discussed.">
            <meta name="citation_description" content="Acromegaly is a complex disease with excessive growth hormone and insulin-like growth factor 1 (IGF-1) causing multisystem effects, particularly cardiovascular, respiratory, and metabolic. Psychological concerns and poor quality of life (QoL) are also major disease consequences. This review is intended for clinicians and focuses on the latest developments related to respiratory and QoL effects of long-term growth hormone excess. Along with biochemical disease control, patient treatment satisfaction and outcomes have become major treatment objectives; current knowledge and tools to evaluate and manage this aspect of the disease are described. Sleep apnea syndrome and other derangements of lung function and apparatus, from pathophysiology to treatment, and evaluation tools and determinants of QoL in patients with acromegaly are discussed.">
            <meta name="citation_keywords" content="Acromegaly, growth hormone excess, respiratory complication, sleep apnea, quality of life, patients reported outcome">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Fabienne Langlois">
            <meta name="citation_author_institution" content="Centre Hospitalier Universitaire de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada">
            <meta name="citation_author" content="Gabriela M. Suarez">
            <meta name="citation_author_institution" content="Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health &amp; Science University, 3303 South Bond Avenue, CH8N, Portland, OR, 97239, USA">
            <meta name="citation_author" content="Maria Fleseriu">
            <meta name="citation_author_institution" content="Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health &amp; Science University, 3303 South Bond Avenue, CH8N, Portland, OR, 97239, USA">
            <meta name="citation_publication_date" content="2020/07/29">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="791">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.22683.1">
            <meta name="citation_firstpage" content="791">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-791/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-791.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=25044 /> <input type=hidden id=articleId name=articleId value=22683 /> <input type=hidden id=xmlUrl value="/articles/9-791/v1/xml"/> <input type=hidden id=xmlFileName value="-9-791-v1.xml"> <input type=hidden id=article_uuid value=5fd8c26a-4493-40d7-bedd-874dae87c8da /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.22683.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.22683.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-791"
  },
  "headline": "Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life...",
  "datePublished": "2020-07-29T14:46:52",
  "dateModified": "2020-07-29T14:46:52",
  "author": [
    {
      "@type": "Person",
      "name": "Fabienne Langlois"
    },    {
      "@type": "Person",
      "name": "Gabriela M. Suarez"
    },    {
      "@type": "Person",
      "name": "Maria Fleseriu"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Acromegaly is a complex disease with excessive growth hormone and insulin-like growth factor 1 (IGF-1) causing multisystem effects, particularly cardiovascular, respiratory, and metabolic. Psychological concerns and poor quality of life (QoL) are also major disease consequences. This review is intended for clinicians and focuses on the latest developments related to respiratory and QoL effects of long-term growth hormone excess. Along with biochemical disease control, patient treatment satisfaction and outcomes have become major treatment objectives; current knowledge and tools to evaluate and manage this aspect of the disease are described. Sleep apnea syndrome and other derangements of lung function and apparatus, from pathophysiology to treatment, and evaluation tools and determinants of QoL in patients with acromegaly are discussed."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-791/v1",
            "name": "Updates in rare and not-so-rare complications of acromegaly: focus..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Updates in rare and not-so-rare complications of acromegaly: focus... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=25044 data-id=22683 data-downloads="" data-views="" data-scholar="10.12688/f1000research.22683.1" data-recommended="" data-doi="10.12688/f1000research.22683.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-791/v1/pdf?article_uuid=5fd8c26a-4493-40d7-bedd-874dae87c8da" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-22683-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-22683-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-22683-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Langlois F, Suarez GM and Fleseriu M. Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):791 (<a class=new-orange href="https://doi.org/10.12688/f1000research.22683.1" target=_blank>https://doi.org/10.12688/f1000research.22683.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-22683-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=22683 id=track-article-signin-22683 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/22683?target=/articles/9-791/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=25044 /> <input name=articleId type=hidden value=22683 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Fabienne Langlois<a href="https://orcid.org/0000-0003-4052-8443" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4052-8443</div><sup>1</sup>,&nbsp;</span><span class="">Gabriela M. Suarez<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:fleseriu@ohsu.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Maria Fleseriu</span></a><a href="https://orcid.org/0000-0001-9284-6289" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9284-6289</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Fabienne Langlois<a href="http://orcid.org/0000-0003-4052-8443" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4052-8443</div><sup>1</sup>,&nbsp;</span><span class="">Gabriela M. Suarez<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:fleseriu@ohsu.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Maria Fleseriu</span></a><a href="http://orcid.org/0000-0001-9284-6289" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9284-6289</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 Jul 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.22683.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Centre Hospitalier Universitaire de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada<br/> <sup>2</sup> Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health &amp; Science University, 3303 South Bond Avenue, CH8N, Portland, OR, 97239, USA<br/> <p> <div class=margin-bottom> Fabienne Langlois <br/> <span>Roles: </span> Investigation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Gabriela M. Suarez <br/> <span>Roles: </span> Investigation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Maria Fleseriu <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Project Administration, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=73144-68283></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=73145-68282></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=73143-68284></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Acromegaly is a complex disease with excessive growth hormone and insulin-like growth factor 1 (IGF-1) causing multisystem effects, particularly cardiovascular, respiratory, and metabolic. Psychological concerns and poor quality of life (QoL) are also major disease consequences. This review is intended for clinicians and focuses on the latest developments related to respiratory and QoL effects of long-term growth hormone excess. Along with biochemical disease control, patient treatment satisfaction and outcomes have become major treatment objectives; current knowledge and tools to evaluate and manage this aspect of the disease are described. Sleep apnea syndrome and other derangements of lung function and apparatus, from pathophysiology to treatment, and evaluation tools and determinants of QoL in patients with acromegaly are discussed. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Acromegaly, growth hormone excess, respiratory complication, sleep apnea, quality of life, patients reported outcome </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Maria Fleseriu (<a href="mailto:fleseriu@ohsu.edu">fleseriu@ohsu.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Maria Fleseriu </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> FL and GMS declare that they have no competing interests. As principal investigator, MF has received research support to Oregon Health & Science University from Novartis, Crinetics, Chiasma, and Ionis and has been an occasional scientific consultant to Novartis, Crinetics, Chiasma, Pfizer, and Ipsen. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2020 Langlois F <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Langlois F, Suarez GM and Fleseriu M. Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):791 (<a href="https://doi.org/10.12688/f1000research.22683.1" target=_blank>https://doi.org/10.12688/f1000research.22683.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 Jul 2020, <b>9</b>(Faculty Rev):791 (<a href="https://doi.org/10.12688/f1000research.22683.1" target=_blank>https://doi.org/10.12688/f1000research.22683.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 Jul 2020, <b>9</b>(Faculty Rev):791 (<a href="https://doi.org/10.12688/f1000research.22683.1" target=_blank>https://doi.org/10.12688/f1000research.22683.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d39561e166>Introduction</h2><p class="" id=d39561e169>Acromegaly is a disorder almost exclusively caused by a pituitary growth hormone (GH)-secreting adenoma. The high circulating levels of GH and resulting insulin-like growth factor 1 (IGF-1) have pleiotropic effects on many organs<sup><a href="#ref-1">1</a></sup>. Ultimately, acromegaly causes an insidious syndrome that severely impacts patient morbidity and quality of life (QoL). Cardiovascular and respiratory complications are frequent comorbidities and are the main causes of mortality among patients<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. Cancer risk is also increased<sup><a href="#ref-4">4</a></sup> and recently cancer has been shown to surpass cardiovascular causes as a main cause of death compared with the general population<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>. However, with advances in treatment and thus improved biochemical control, mortality has diminished over the past decade<sup><a href="#ref-7">7</a></sup>. See <a href="#T1">Table 1</a> on multisystem acromegaly complications<sup><a href="#ref-2">2</a>,<a href="#ref-8">8</a>–<a href="#ref-12">12</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Multisystem acromegaly complications.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d39561e223 class=n-a></a><thead><a name=d39561e225 class=n-a></a><tr><a name=d39561e227 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d39561e229 class=n-a></a>System</th></tr></thead><tbody><a name=d39561e234 class=n-a></a><tr><a name=d39561e236 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e237 class=n-a></a>Cardiovascular</td></tr><tr><a name=d39561e240 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e241 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Cardiomyopathy characterized by biventricular hypertrophy or fibrosis or both<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Hyperkinetic syndrome<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Diastolic or systolic dysfunction or both<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Arterial hypertension<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Valvulopathies<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Arrhythmias<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Vascular endothelial dysfunction</td></tr><tr><a name=d39561e257 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e258 class=n-a></a>Musculoskeletal </td></tr><tr><a name=d39561e261 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e262 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Enlargement/elongation of vertebral bodies<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Disrupted trabecular bone architecture and vertebral compression fractures<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Thoracic spine kyphoscoliosis<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Overgrowth of mandible, malocclusion, and increased teeth spacing<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Myopathy, including airway muscle fatigue</td></tr><tr><a name=d39561e273 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e274 class=n-a></a>Metabolic</td></tr><tr><a name=d39561e278 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e279 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Insulin resistance and diabetes mellitus<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Dyslipidemia: hypertriglyceridemia and low high-density lipoprotein cholesterol<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Hyperandrogenemia with a polycystic ovary syndrome-like effect<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Hypertrichosis</td></tr><tr><a name=d39561e288 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e289 class=n-a></a>Respiratory</td></tr><tr><a name=d39561e292 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e293 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Upper airway narrowing, including tracheal stenosis and tortuosity<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Macroglossia<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Tracheo-bronchomegaly<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Thickening of true and false vocal cords<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Increased lung volume<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Possible decreased lung compliance<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Small airway obstruction<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Obstructive and central sleep apnea</td></tr><tr><a name=d39561e311 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e312 class=n-a></a>Psychological</td></tr><tr><a name=d39561e315 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e316 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Emotional lability<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Social withdrawal<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Distorted body image<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Diminished quality of life</td></tr><tr><a name=d39561e325 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e326 class=n-a></a>Gastrointestinal</td></tr><tr><a name=d39561e330 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e331 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Increased colonic polyps<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;Dolichocolon</td></tr></tbody></table></div><p class="" id=d39561e339>Cardiovascular complications and cancer have been extensively reviewed as complications of acromegaly<sup><a href="#ref-13">13</a></sup>. The focus here is on the latest developments related to respiratory and QoL effects.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39561e349>Respiratory complications</h2><div class=section><a name=d39561e352 class=n-a></a><h3 class=section-title>Background</h3><p class="" id=d39561e357>Patients with acromegaly have been reported to have a 1.85 times higher risk of developing respiratory diseases versus the general population<sup><a href="#ref-14">14</a></sup>. One of the most common complications of acromegaly is obstructive sleep apnea (OSA); the risk is approximately 10-fold in acromegaly compared with the general population<sup><a href="#ref-15">15</a>–<a href="#ref-17">17</a></sup>. OSA can exacerbate cardiovascular dysfunction and is an important contributor to impaired QoL and eventually mortality<sup><a href="#ref-18">18</a></sup>. Lesser-known facets of acromegaly-induced respiratory complications affect pulmonary function, oximetry, and exercise capacity<sup><a href="#ref-13">13</a>,<a href="#ref-19">19</a></sup>. Excess GH, on the surface, would seem to be beneficial to physical performance; however, it can also have deleterious effects and contribute to significant fatigue and inability to sustain similar workloads compared with controls<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. Overall, the mortality rates from respiratory causes are three times higher when compared with that of the general population<sup><a href="#ref-21">21</a>–<a href="#ref-23">23</a></sup> and contribute to up to one fifth of acromegaly-related deaths<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup>.</p></div><div class=section><a name=d39561e405 class=n-a></a><h3 class=section-title>Pathophysiology</h3><p class="" id=d39561e410>Mechanisms by which acromegaly is associated with respiratory complications are not clearly understood. However, there are several proposed mechanisms by which GH can alter lung anatomy; the main hypotheses are as follows:</p><p class="" id=d39561e413>1. Upper respiratory airways. High GH/IGF-1 can lead to deformities of facial bones, hypertrophy of the pharyngeal and laryngeal cartilages, and soft tissue thickening and macroglossia, which ultimately can lead to inspiratory collapse of the hypopharynx, especially during sleep<sup><a href="#ref-2">2</a>,<a href="#ref-14">14</a>,<a href="#ref-26">26</a>–<a href="#ref-28">28</a></sup>. Also, generalized tissue edema, related to high sodium and volume reabsorption by the kidney, which contributes to upper airway narrowing, may be observed in patients with acromegaly<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. Ultimately, external compression can occur because of goiter or accumulation of fat and contribute to tracheal deviation, tortuosity, and sometimes stenosis<sup><a href="#ref-31">31</a></sup>.</p><p class="" id=d39561e440>2. Lung volumes. GH stimulates lung growth by increasing the number or size of alveoli (or both)<sup><a href="#ref-14">14</a>,<a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>. Data on histopathology of human lungs in patients with acromegaly are lacking, and clinical data from pulmonary function tests sometimes render conflicting results. In general, increased total lung volumes are measured by total lung capacity, vital capacity, and residual volumes, all of which can be 110 to 160% of a predicted value<sup><a href="#ref-26">26</a>,<a href="#ref-34">34</a>–<a href="#ref-39">39</a></sup>. This is related to the direct effect of GH/IGF-1 inducing alveoli hyperplasia, alveoli hypertrophy, or an increase in alveoli number or a combination of these<sup><a href="#ref-26">26</a>,<a href="#ref-34">34</a></sup>. Increased lung mass has also been objectively measured by computed tomography (CT) densitovolumetry; active acromegaly compared with controls revealed a 25% mass increase: 885 g versus 696 g (<i>P</i> = 0.017)<sup><a href="#ref-37">37</a></sup>.</p><p class="" id=d39561e477>3. Thoracic musculature. GH and IGF-1 exert proliferative but also degenerative effects on smooth muscle, inducing respiratory muscle dystrophia. Myopathy is evident on pathology as muscle fiber degeneration and abnormal collagen are observed<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. These findings translate to enhanced muscle fatigue, as demonstrated in a murine model with effects on sternohyodal muscle<sup><a href="#ref-42">42</a></sup>.</p><p class="" id=d39561e492>4. Thoracic bone changes. The axial skeleton is affected in up to 60% of patients, and changes include thickening of soft and cartilaginous tissues, rib cage deformity, formation of osteophytes, and abnormal trabecular bone microarchitecture leading to vertebral fractures and kyphoscoliosis<sup><a href="#ref-38">38</a></sup>.</p><p class="" id=d39561e499>5. Diffusing capacity. Diffusing capacity of the lung for carbon monoxide (DLCO) can also be altered. Some studies reported a lower DLCO<sup><a href="#ref-27">27</a></sup>, most showed neutral diffusing capacity<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a>,<a href="#ref-34">34</a>,<a href="#ref-35">35</a>,<a href="#ref-38">38</a>,<a href="#ref-43">43</a></sup>, and some found an increased DLCO<sup><a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>. Higher lung volumes could lead to an increase in DLCO; therefore, diffusing capacity corrected for alveolar volume is likely to be normal in patients with acromegaly<sup><a href="#ref-46">46</a></sup>.</p><p class="" id=d39561e536>6. Lung compliance. Lung elasticity may also change due to excess GH/IGF-1. Decreased lung recoil might be explained by elevated peripheral rib cage resistance caused by hypertrophic muscles and rib cage or caused by obesity<sup><a href="#ref-26">26</a></sup> but could also be related to a higher alveoli size<sup><a href="#ref-43">43</a></sup>. Some series did not demonstrate a change (ref 34) in lung elasticity and one (ref 43) showed that patients with acromegaly had higher lung distensibility, which was partially reversible after treatment<sup><a href="#ref-34">34</a>,<a href="#ref-43">43</a></sup>. Various components of lung compliance may be differently affected in the disease and may explain the heterogeneity of results.</p><p class="" id=d39561e554>7. Obstructive disease. Small airway obstruction is evident on the basis of a reduced maximum expiratory flow after 75% of forced vital capacity had been exhaled (FEF75). Moreover, more than half of patients had clinically important reductions (&lt;80% of predicted value) in FEF75<sup><a href="#ref-38">38</a>,<a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>. Up to 60% of air trapping causing ventilation perfusion mismatches was reported<sup><a href="#ref-38">38</a></sup>. This small airway obstruction might be due to increased thickness or tortuosity of the bronchial wall, increased lung volumes, or vascular congestion or a combination of these<sup><a href="#ref-38">38</a></sup>.</p><p class="" id=d39561e575>8. Bronchiectasis was also noted on high-resolution CT but might not be more prevalent than what is observed in healthy subjects<sup><a href="#ref-49">49</a></sup>.</p></div><div class=section><a name=d39561e583 class=n-a></a><h3 class=section-title>Diagnosis and management</h3><p class="" id=d39561e588><b><i>Sleep apnea in patients with acromegaly.</i></b> In different series, sleep apnea affects up to 80% of patients and represents a 10-fold increased risk compared with the general population<sup><a href="#ref-11">11</a>,<a href="#ref-13">13</a>,<a href="#ref-50">50</a></sup>. A main symptom of OSA is daytime sleepiness caused by repeated micro-arousal due to hypoxemic events during sleep<sup><a href="#ref-50">50</a></sup>. Acromegaly is predominantly associated with OSA, caused by upper airway obstruction<sup><a href="#ref-2">2</a>,<a href="#ref-18">18</a>,<a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>. However, central sleep apnea also occurs, as about 30% of patients with acromegaly have a central sleep apnea component<sup><a href="#ref-53">53</a>–<a href="#ref-56">56</a></sup>. Pathogenesis remains controversial but might be directly GH-mediated or related to associated cardiomyopathy<sup><a href="#ref-56">56</a>,<a href="#ref-57">57</a></sup>. Excess GH is associated with central inhibition of the breathing center and may lower the ventilatory response of the respiratory center to carbon dioxide, resulting in a temporary cessation of the respiratory center and respiratory efforts<sup><a href="#ref-56">56</a></sup>.</p><p class="" id=d39561e640>Other factors, notably obesity, concomitant hypothyroidism, and treatment of hypogonadism, also play a role in OSA<sup><a href="#ref-13">13</a></sup>. Hypogonadism in male patients with acromegaly and OSA is frequent. Hormonal replacement should be undertaken with caution, especially in cases of severe untreated OSA since there is some evidence that testosterone might deteriorate OSA<sup><a href="#ref-58">58</a></sup>.</p><p class="" id=d39561e651>If sleep apnea is left untreated, it can lead to fatigue, daytime sleepiness, hypogonadism, arterial and pulmonary hypertension, ischemic heart disease, right ventricular failure, cerebrovascular accidents, life-threatening arrhythmias, poor QoL, and cognitive dysfunction<sup><a href="#ref-14">14</a>,<a href="#ref-18">18</a>,<a href="#ref-50">50</a>,<a href="#ref-52">52</a>,<a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. Usual predictors such as age, male sex, neck circumference, and body mass index (BMI) are factors associated with the onset and severity of OSA, but finger circumference is an additional predictor specific to acromegaly<sup><a href="#ref-11">11</a>,<a href="#ref-18">18</a>,<a href="#ref-61">61</a>–<a href="#ref-64">64</a></sup>. Use of the Epworth Sleepiness Scale or the STOP-Bang (snoring, tiredness, observed apnea, high blood pressure, BMI, age, neck circumference, and male sex) questionnaire can help identify patients, in the general population, but more studies are needed in patients with acromegaly, and polysomnography remains key for diagnosis<sup><a href="#ref-18">18</a>,<a href="#ref-50">50</a>,<a href="#ref-65">65</a></sup>.</p><p class="" id=d39561e696>It is still a matter of debate whether OSA severity is associated with disease activity or disease duration or both<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>. Some reversibility of OSA may be observed once biochemical control is achieved, but a recent meta-analysis confirms that the prevalence of OSA in patients with controlled acromegaly is similar to that in patients with uncontrolled acromegaly<sup><a href="#ref-68">68</a></sup>. Nonetheless, acromegaly patients who underwent treatment have been shown to have improvement in both central and peripheral component of sleep-breathing control, especially by reducing soft tissue swelling and macroglossia<sup><a href="#ref-14">14</a>,<a href="#ref-18">18</a>,<a href="#ref-54">54</a>,<a href="#ref-61">61</a>,<a href="#ref-69">69</a></sup>. However, changes in bones and cartilaginous structures affecting upper airway anatomy may be irreversible<sup><a href="#ref-13">13</a></sup>, and even worsening or <i>de novo</i> OSA, partly related to weight gain after cure, may occur<sup><a href="#ref-16">16</a>,<a href="#ref-18">18</a></sup>.</p><p class="" id=d39561e742>In general, prospective studies suggest that more than 50% of patients with controlled acromegaly continue to have persistent OSA<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a>,<a href="#ref-55">55</a></sup>. Most improvement is attained in the first year after treatment<sup><a href="#ref-55">55</a></sup>. Pituitary surgery has been reported to improve sleep apnea and decrease the frequency of apneic and hypopneic episodes by 50 to 60% in a surgically cured cohort<sup><a href="#ref-39">39</a>,<a href="#ref-62">62</a></sup>. Medical treatment also leads to improvement in apnea–hypopnea index (AHI), as indices of oxygen desaturation, sleep quality, and subjective sleepiness improved after 6 months of octreotide treatment in approximately half of cases<sup><a href="#ref-70">70</a></sup>. Intriguingly, AHI changes in patients do not always correlate with GH or IGF-1 levels, and other factors such as age, sex, and smoking also prevail<sup><a href="#ref-71">71</a></sup>. Interestingly, one factor influencing AHI is weight, as OSA did not improve and may occur <i>de novo</i> in patients who gained weight after treatment<sup><a href="#ref-72">72</a></sup>.</p><p class="" id=d39561e782>Overall, evaluating patients with acromegaly for OSA at diagnosis is mandatory<sup><a href="#ref-73">73</a></sup>. A diagnostic procedure such as polysomnography or home sleep apnea testing should be ordered if clinical suspicion exists. Screening of every patient could be done since the pre-test probability is very high. Follow-up by periodic re-evaluation of OSA is warranted at least 1 year after successful treatment<sup><a href="#ref-74">74</a></sup>. Attention to weight gain and physiological hormonal replacement in the post-treatment period may help improve OSA<sup><a href="#ref-13">13</a></sup>.</p><p class="" id=d39561e797><b><i>Pulmonary function abnormalities.</i></b> No definite management concerning respiratory insufficiency exists. Biochemical remission does not seem to improve lung function parameters in most patients<sup><a href="#ref-39">39</a></sup>. Pulmonary function tests (spirometry and diffusing capacity) may be ordered in a patient with unexplained shortness of breath or decreased exercise capacity, but cardiovascular dysfunction may also be a cause. No specific treatment has been proposed and tested in this population, but either inhalotherapy or other treatment modalities may be individualized according to findings.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39561e811>Quality of life</h2><p class="" id=d39561e814>Acromegaly is a chronic disease with multiple physical and psychological complications that carry a significant disease burden. Most patients have joint pain, headaches, low energy and libido, and morphological changes such as craniofacial deformation. These changes may not be completely reversible after treatment and can negatively affect QoL<sup><a href="#ref-75">75</a></sup>. The comorbidities and active symptomatology also negatively affect patient productivity and entail high costs related to sick leave, unemployment, or disability<sup><a href="#ref-76">76</a>,<a href="#ref-77">77</a></sup>. Other factors, such as cognitive dysfunction and restless leg syndrome, are more prevalent in patients with acromegaly and are associated with poor QoL<sup><a href="#ref-78">78</a>,<a href="#ref-79">79</a></sup>. Moreover, diagnosis delay and acceptance of the disease could be challenging for patients<sup><a href="#ref-80">80</a>,<a href="#ref-81">81</a></sup>. <a href="#f1">Figure 1</a> (Gadelha <i>et al</i>.) summarizes the factors affecting QoL in acromegaly<sup><a href="#ref-13">13</a></sup>.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/25044/54503cf5-6b1e-4e77-9cc4-1b2bff0b67cb_figure1.gif"><img alt="54503cf5-6b1e-4e77-9cc4-1b2bff0b67cb_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/25044/54503cf5-6b1e-4e77-9cc4-1b2bff0b67cb_figure1.gif"></a><div class=caption><h3>Figure 1. Factors affecting quality of life in patients with acromegaly. [© 2019 Illustration Presentation ENDOCRINE SOCIETY].</h3><p id=d39561e863>GH, growth hormone. The figure was reproduced from Gadelha MR <i>et al.,</i> Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update, Endocrine Reviews, 2019, Volume 40, Issue 1, Pages 268–332<sup><a href="#ref-13">13</a></sup> by permission of the Endocrine Society.</p></div></div><p class="" id=d39561e877>QoL is defined as the patient’s perception of his or her physical and mental health, cognitive function, anxiety, depression, and subjective feelings of energy levels. QoL is considered an important endpoint in the evaluation of patients with acromegaly. It can be measured with questionnaires designed for use in the general population or aimed at specific disease dimension conditions, such as disease-generated or -specific questionnaires like the Acromegaly Quality of Life (AcroQoL) questionnaire<sup><a href="#ref-75">75</a>,<a href="#ref-82">82</a></sup>. <a href="#T2">Table 2</a> presents brief details of the following questionnaires: the Symptom Questionnaire<sup><a href="#ref-83">83</a>,<a href="#ref-84">84</a></sup>, Signs and Symptoms Score<sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>, the Patient-Assessed Acromegaly Symptom Questionnaire<sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>, Short-Form Health Survey (SF-36)<sup><a href="#ref-87">87</a>–<a href="#ref-89">89</a></sup>, the Multidimensional Fatigue Inventory (MFI-20)<sup><a href="#ref-90">90</a>,<a href="#ref-91">91</a></sup>, the Nottingham Health Profile<sup><a href="#ref-92">92</a>,<a href="#ref-93">93</a></sup>, Health-Related Quality of Life<sup><a href="#ref-12">12</a>,<a href="#ref-94">94</a></sup>, Psychological General Well-Being<sup><a href="#ref-82">82</a>,<a href="#ref-95">95</a></sup>, the Hospital Anxiety and Depression Scale<sup><a href="#ref-96">96</a>,<a href="#ref-97">97</a></sup>, the AcroQoL Questionnaire<sup><a href="#ref-75">75</a>,<a href="#ref-82">82</a>,<a href="#ref-96">96</a>,<a href="#ref-98">98</a></sup>, and the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ)<sup><a href="#ref-99">99</a>,<a href="#ref-100">100</a></sup>.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Questionnaires to evaluate quality of life in acromegaly.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d39561e986 class=n-a></a><thead><a name=d39561e988 class=n-a></a><tr><a name=d39561e990 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d39561e992 class=n-a></a>Questionnaires to evaluate<br class=br>quality of life in acromegaly</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39561e997 class=n-a></a>Description</th></tr></thead><tbody><a name=d39561e1002 class=n-a></a><tr><a name=d39561e1004 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1005 class=n-a></a>Symptom Questionnaire</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1008 class=n-a></a>The Symptom Questionnaire is a 92-item questionnaire assessing four scales: anxiety, depression,<br class=br>somatic symptoms, and anger/hostility. Subjects indicate the frequency of symptoms in the past week on<br class=br>a scale from absent to very often. Higher scores indicate greater symptom severity. This questionnaire<br class=br>may be more sensitive in discriminating between distress levels than other tests<sup><a href="#ref-83">83</a>,<a href="#ref-84">84</a></sup>.</td></tr><tr><a name=d39561e1024 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1025 class=n-a></a>Signs and Symptoms Score<br class=br>(SSS) </td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1030 class=n-a></a>The SSS questionnaire is designed specifically to measure acromegaly-related signs and symptoms<br class=br>such as headache, perspiration, joint pain, fatigue, and soft tissue swelling. Each of those five questions<br class=br>is evaluated by a score from 0 (absent) to 8 (severe) for a maximum of 40 indicative, very severe clinical<br class=br>manifestations<sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>.</td></tr><tr><a name=d39561e1046 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1047 class=n-a></a>Patient-Assessed Acromegaly<br class=br>Symptom Questionnaire<br class=br>(PASQ)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1054 class=n-a></a>The PASQ is a disease-specific questionnaire composed of seven questions. The first six questions<br class=br>evaluate physical symptoms (headache, perspiration, joint pain, fatigue, soft tissue swelling, and<br class=br>paresthesia of the extremities) and a seventh question evaluates overall well-being. Each aspect is<br class=br>scored from 0 to 8; a lower score reflects low disease impact and a higher score reflects a more severe<br class=br>disease burden<sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>.</td></tr><tr><a name=d39561e1072 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1073 class=n-a></a>Short-Form Health Survey<br class=br>(SF-36)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1078 class=n-a></a>The SF-36 is a validated self-administered questionnaire that evaluates physical and psychological<br class=br>symptoms and their impact on daily life. Eight domains are explored: physical functioning, role limitations<br class=br>due to physical functioning, general health perception, pain, vitality, emotional well-being, role limitations<br class=br>due to emotional health, and social functioning. SF-36 consists of 36 questions answered with either “yes/<br class=br>no” responses or scaled responses ranging from three options (“yes, limited a lot”, “yes, limited a little”,<br class=br>or “no, not limited at all”) to six options (“all of the time”, “most of the time”, “a good bit of the time”, “some<br class=br>of the time”, “a little of the time”, or “none of the time”). Higher scores indicate a better quality of life<sup><a href="#ref-87">87</a>–<a href="#ref-89">89</a></sup>.</td></tr><tr><a name=d39561e1101 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1102 class=n-a></a>Multidimensional Fatigue<br class=br>Inventory (MFI-20)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1107 class=n-a></a>The MFI-20 contains 20 statements to assess fatigue. There are five different dimensions of fatigue and<br class=br>each contains four items. The dimensions are general fatigue, physical fatigue, reduced activity, reduced<br class=br>motivation, and mental fatigue. Items are rated on a scale from 0 (absent) to 5 (extremely). A higher score<br class=br>indicates more fatigue experienced<sup><a href="#ref-90">90</a>,<a href="#ref-91">91</a></sup>.</td></tr><tr><a name=d39561e1124 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1125 class=n-a></a>Nottingham Health Profile<br class=br>(NHP)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1130 class=n-a></a>The NHP is frequently used in patients with pituitary disease to assess general well-being and QoL. This<br class=br>survey consists of 38 “yes/no” questions that are subdivided into six scales assessing impairments:<br class=br>pain (eight items), energy level (three items), sleep (five items), emotional reactions (nine items), social<br class=br>isolation (five items), and disability/functioning (i.e., physical mobility) (eight items). A higher score is<br class=br>associated with more impairment<sup><a href="#ref-92">92</a>,<a href="#ref-93">93</a></sup>.</td></tr><tr><a name=d39561e1148 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1149 class=n-a></a>Health-Related Quality of Life<br class=br>(HRQoL)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1154 class=n-a></a>This is a 15-item, standardized, self-administered HRQoL instrument that can be used both as a profile<br class=br>and as a single-index score measure. The 15 items evaluated are moving, seeing, hearing, breathing,<br class=br>sleeping, eating, speech, eliminating, usual activities, mental function, discomfort and symptoms,<br class=br>depression, distress, vitality, and sexual activity. For each item, the patient chooses one of the five levels<br class=br>that best describes his or her state of health at that moment<sup><a href="#ref-12">12</a>,<a href="#ref-94">94</a></sup>.</td></tr><tr><a name=d39561e1172 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1173 class=n-a></a>The Psychological General<br class=br>Well-Being (PGWB)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1178 class=n-a></a>The PGWB Index is a 22-item questionnaire that evaluates six subscales: anxiety, depressed mood,<br class=br>positive well-being, self-control, general health, and vitality. Each item has six questions, which are<br class=br>scored from 0 to 5. A score of 110 represents a perfect QOL<sup><a href="#ref-82">82</a>,<a href="#ref-95">95</a></sup></td></tr><tr><a name=d39561e1191 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1192 class=n-a></a>Hospital Anxiety and<br class=br>Depression Scale (HADS)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1197 class=n-a></a>This is a 14-item questionnaire evaluating anxiety and depression. Each item is scored on a 4-point scale.<br class=br>Scores range from 0 to 21 for the anxiety and depression subscale and from 0 to 42 for the total score.<br class=br>Higher scores indicate higher levels of anxiety and depression<sup><a href="#ref-96">96</a>,<a href="#ref-97">97</a></sup>.</td></tr><tr><a name=d39561e1211 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1212 class=n-a></a>AcroQoL Questionnaire</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1215 class=n-a></a>The AcroQoL Questionnaire has been used and validated in randomized clinical trials, leading to a better<br class=br>understating of the specific impairments in acromegaly. This questionnaire consists of 22 questions that<br class=br>evaluate physical and psychological dimensions. Answers are recorded on a scale from 1 (always or<br class=br>completely agree) to 5 (never or completely disagree). The maximum score of 110 reflects best possible<br class=br>QoL and is quoted as a percentage (e.g., 100%). The 22 items evaluate physical symptoms such as<br class=br>pain and fatigue and psychological function, such as impact on appearance, performance, and personal<br class=br>relationships<sup><a href="#ref-75">75</a>,<a href="#ref-82">82</a>,<a href="#ref-96">96</a>,<a href="#ref-98">98</a></sup>.</td></tr><tr><a name=d39561e1244 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1245 class=n-a></a>Acromegaly Treatment<br class=br>Satisfaction Questionnaire<br class=br>(Acro-TSQ)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1252 class=n-a></a>This questionnaire is a novel tool to simultaneously evaluate patient satisfaction on disease and treatment<br class=br>with somatostatin receptor ligand. It measures treatment effectiveness, symptom burden, treatment side<br class=br>effects, convenience of treatment, and overall satisfaction over the past 4 weeks<sup><a href="#ref-99">99</a>,<a href="#ref-100">100</a></sup>.</td></tr></tbody></table></div><p class="" id=d39561e1270>A systematic review confirmed that AcroQoL scores are significantly impaired in patients with acromegaly<sup><a href="#ref-101">101</a></sup>. Geraedts <i>et al</i>. showed that the most significant factors associated with poor QoL were depression and higher BMI<sup><a href="#ref-102">102</a></sup>. Other predictors have been inconsistently identified; longer disease duration, painful syndrome (musculoskeletal or headache), diabetes, older age, female gender, having received treatment with radiotherapy, and becoming GH-deficient after treatment<sup><a href="#ref-75">75</a>,<a href="#ref-102">102</a>,<a href="#ref-103">103</a></sup>. Successful therapy might improve QoL but may not normalize QoL completely, even after biochemical cure<sup><a href="#ref-75">75</a>,<a href="#ref-104">104</a>–<a href="#ref-107">107</a></sup>. Indeed, QoL has been shown to be severely impaired years after successful treatment in patients with acromegaly compared with the general population<sup><a href="#ref-104">104</a>,<a href="#ref-108">108</a>,<a href="#ref-109">109</a></sup>.</p><div class=section><a name=d39561e1315 class=n-a></a><h3 class=section-title>Quality of life after treatment</h3><p class="" id=d39561e1320>Numerous studies have looked at the impact of different treatment modalities in first- or second-line therapies. Pituitary surgery compared with medical treatment seems superior in improving QoL in patients with acromegaly<sup><a href="#ref-101">101</a></sup> as in other types of pituitary tumor<sup><a href="#ref-110">110</a></sup>. A French study found that patients who underwent surgery had a better QoL than if they had received medical treatment only (65 ± 18% versus 54 ± 14%, <i>P</i> = 0.009), and investigators concluded that neurosurgery was associated with greater improvement in QoL when compared with medical therapy alone<sup><a href="#ref-111">111</a></sup>. Overall, greater GH suppression could be attained with surgery than with somatostatin receptor ligand (SRL) injections<sup><a href="#ref-112">112</a></sup>. Indeed, patients with remission after surgery could avoid medication side effects and consequences of suboptimal biochemical control.</p><p class="" id=d39561e1342>Types of medical therapy used rendered heterogeneous results on QoL, see <a href="#T3">Table 3</a><sup><a href="#ref-113">113</a>–<a href="#ref-125">125</a></sup>. Some studies with first-line SRL injections in treatment-naïve patients show improved QoL in patients who received long-acting lanreotide<sup><a href="#ref-114">114</a>,<a href="#ref-115">115</a></sup>, but the results were controversial<sup><a href="#ref-106">106</a>,<a href="#ref-116">116</a>,<a href="#ref-124">124</a>,<a href="#ref-126">126</a></sup>. On the other hand, a multicenter study showed that two thirds of patients controlled on SRL injections reported ongoing incommoding acromegaly symptoms<sup><a href="#ref-127">127</a></sup>. In that study, gastrointestinal disturbances were very frequent (73%); this was possibly related to SRL side effects or disease activity itself<sup><a href="#ref-127">127</a></sup>. A new questionnaire, Acro-TSQ, was developed to evaluate QoL specifically in patients who received injectable SRLs and provides further insight<sup><a href="#ref-99">99</a></sup>.</p><a name=T3 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 3. Prospective studies on effect of pharmacotherapy on quality of life.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d39561e1398 class=n-a></a><thead><a name=d39561e1400 class=n-a></a><tr><a name=d39561e1402 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d39561e1404 class=n-a></a>Therapy</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39561e1407 class=n-a></a>Publication</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39561e1410 class=n-a></a>Number<br class=br>of<br class=br>patients</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39561e1417 class=n-a></a>Follow-up,<br class=br>Weeks</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39561e1422 class=n-a></a>Disease status<br class=br>(for majority of<br class=br>patients)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39561e1430 class=n-a></a>Medical treatment in<br class=br>control group</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39561e1435 class=n-a></a>Scales<br class=br>used</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39561e1440 class=n-a></a>Effect on<br class=br>quality of<br class=br>life</th></tr></thead><tbody><a name=d39561e1449 class=n-a></a><tr><a name=d39561e1451 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1452 class=n-a></a>Lanreotide Autogel</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1455 class=n-a></a>Sonino <i>et al.</i> (1999)<sup><a href="#ref-113">113</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1464 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1467 class=n-a></a>8 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1470 class=n-a></a>Uncontrolled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1473 class=n-a></a>Octreotide LAR or<br class=br>bromocriptine</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1479 class=n-a></a>KSQ,<br class=br>CSKSLPP</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1484 class=n-a></a>↑↑ </td></tr><tr><a name=d39561e1487 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1488 class=n-a></a>Lanreotide Autogel</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1491 class=n-a></a>Lombardi <i>et al.</i> (2009)<sup><a href="#ref-114">114</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1500 class=n-a></a>51</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1503 class=n-a></a>52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1506 class=n-a></a>Uncontrolled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1509 class=n-a></a>Treatment naïve</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1513 class=n-a></a>NHP</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1516 class=n-a></a>↑↑ </td></tr><tr><a name=d39561e1519 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1520 class=n-a></a>Lanreotide Autogel</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1523 class=n-a></a>Caron <i>et al.</i> (2016)<sup><a href="#ref-115">115</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1532 class=n-a></a>90</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1535 class=n-a></a>48</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1538 class=n-a></a>Uncontrolled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1541 class=n-a></a>Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1545 class=n-a></a>AcroQoL,<br class=br>PASQ</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1550 class=n-a></a>↑↑ </td></tr><tr><a name=d39561e1553 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1554 class=n-a></a>Lanreotide Autogel</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1557 class=n-a></a>Schopohl <i>et al.</i> (2011)<sup><a href="#ref-116">116</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1566 class=n-a></a>37</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1569 class=n-a></a>26–52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1572 class=n-a></a>Controlled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1575 class=n-a></a>Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1579 class=n-a></a>AcroQoL</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1582 class=n-a></a>↔</td></tr><tr><a name=d39561e1585 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1586 class=n-a></a>Octreotide LAR<br class=br>intensification</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1591 class=n-a></a>Mangupli <i>et al.</i> (2014)<sup><a href="#ref-117">117</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1600 class=n-a></a>28</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1603 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1606 class=n-a></a>Uncontrolled </td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1609 class=n-a></a>Treatment naïve or<br class=br>Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1615 class=n-a></a>AcroQoL</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1618 class=n-a></a>↑↑ </td></tr><tr><a name=d39561e1622 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1623 class=n-a></a>Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1626 class=n-a></a>Chin <i>et al.</i> (2015)<sup><a href="#ref-118">118</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1635 class=n-a></a>58</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1638 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1641 class=n-a></a>Uncontrolled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1644 class=n-a></a>Treatment naïve</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1648 class=n-a></a>AcroQoL </td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1651 class=n-a></a>↑ </td></tr><tr><a name=d39561e1654 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1655 class=n-a></a>Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1658 class=n-a></a>Ghigo <i>et al.</i> (2009)<sup><a href="#ref-119">119</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1667 class=n-a></a>57</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1670 class=n-a></a>48</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1673 class=n-a></a>Uncontrolled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1676 class=n-a></a>Treatment naïve</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1680 class=n-a></a>AcroQoL,<br class=br>SSS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1685 class=n-a></a>↑↑ </td></tr><tr><a name=d39561e1688 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1689 class=n-a></a>Octreotide LAR<br class=br>every 6 weeks</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1694 class=n-a></a>Biermasz <i>et al.</i> (2003)<sup><a href="#ref-120">120</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1703 class=n-a></a>14</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1706 class=n-a></a>36</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1709 class=n-a></a>Controlled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1712 class=n-a></a>Octreotide LAR<br class=br>every 4 weeks</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1718 class=n-a></a>NHP</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1721 class=n-a></a>↔</td></tr><tr><a name=d39561e1724 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1725 class=n-a></a>Octreotide LAR or<br class=br>Lanreotide Autogel<br class=br>intensification</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1732 class=n-a></a>Dal <i>et al.</i> (2018)<sup><a href="#ref-121">121</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1741 class=n-a></a>61</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1744 class=n-a></a>52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1747 class=n-a></a>Controlled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1750 class=n-a></a>Octreotide LAR or<br class=br>Lanreotide Autogel</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1756 class=n-a></a>AcroQoL,<br class=br>PASQ</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1761 class=n-a></a>↔</td></tr><tr><a name=d39561e1764 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1765 class=n-a></a>Pasireotide</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1768 class=n-a></a>Bronstein <i>et al.</i> (2016)<sup><a href="#ref-122">122</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1777 class=n-a></a>119</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1780 class=n-a></a>52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1783 class=n-a></a>Uncontrolled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1786 class=n-a></a>Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1790 class=n-a></a>AcroQoL</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1793 class=n-a></a>↔</td></tr><tr><a name=d39561e1796 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1797 class=n-a></a>Pegvisomant</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1800 class=n-a></a>Ghigo <i>et al.</i> (2009)<sup><a href="#ref-119">119</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1809 class=n-a></a>56</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1812 class=n-a></a>48</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1815 class=n-a></a>Uncontrolled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1818 class=n-a></a>Treatment naïve</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1822 class=n-a></a>AcroQoL,<br class=br>SSS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1827 class=n-a></a>↑↑ </td></tr><tr><a name=d39561e1831 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1832 class=n-a></a>Pegvisomant</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1835 class=n-a></a>Trainer <i>et al.</i> (2009)<sup><a href="#ref-123">123</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1844 class=n-a></a>52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1847 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1850 class=n-a></a>Uncontrolled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1853 class=n-a></a>Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1857 class=n-a></a>AcroQoL,<br class=br>EQ-5D</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1862 class=n-a></a>↑↑ (only<br class=br>AcroQoL)</td></tr><tr><a name=d39561e1867 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1868 class=n-a></a>Pegvisomant weekly<br class=br>or twice weekly</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1873 class=n-a></a>Higham <i>et al.</i> (2009)<sup><a href="#ref-128">128</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1882 class=n-a></a>7</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1885 class=n-a></a>32</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1888 class=n-a></a>Controlled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1891 class=n-a></a>Pegvisomant daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1895 class=n-a></a>AcroQoL</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1898 class=n-a></a>↔</td></tr><tr><a name=d39561e1901 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1902 class=n-a></a>Pegvisomant - <br class=br>Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1907 class=n-a></a>Trainer <i>et al.</i> (2009)<sup><a href="#ref-123">123</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1916 class=n-a></a>53</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1919 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1922 class=n-a></a>Uncontrolled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1925 class=n-a></a>Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1929 class=n-a></a>AcroQoL,<br class=br>EQ-5D</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1934 class=n-a></a>↑↑ (only<br class=br>AcroQoL)</td></tr><tr><a name=d39561e1939 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1940 class=n-a></a>Pegvisomant -<br class=br> Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1945 class=n-a></a>Neggers <i>et al.</i> (2008)<sup><a href="#ref-124">124</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1954 class=n-a></a>20</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1957 class=n-a></a>36</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1960 class=n-a></a>Controlled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1963 class=n-a></a>Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1967 class=n-a></a>AcroQoL,<br class=br>PASQ</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1972 class=n-a></a>↑↑ </td></tr><tr><a name=d39561e1975 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1976 class=n-a></a>Pegvisomant -<br class=br> Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1981 class=n-a></a>Madsen <i>et al.</i> (2011)<sup><a href="#ref-125">125</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1990 class=n-a></a>18</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1993 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1996 class=n-a></a>Controlled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e1999 class=n-a></a>Octreotide LAR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e2003 class=n-a></a>EQ-5D,<br class=br>PASQ</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39561e2008 class=n-a></a>↔</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d39561e2016 class=n-a></a><p id=d39561e2018> ↑, improvement in quality of life (QoL) subscale only; ↑↑, improvement in global QoL; ↔, no significant change in QoL; CSKSLPP, Cognitive Scale of Kellner’s Screening List for Psychosocial Problems; EQ-5D, European quality of life scale; KSQ, Kellner’s Symptom Questionnaire (psychological distress and well-being); LAR, long-acting release; NHP, Nottingham Health Profile; PASQ, Patient-Assessed Acromegaly Symptom Questionnaire; SF-36, Short-Form Health Survey; SSS, Signs and Symptoms Scale—acromegaly. This table was adapted from Gadelha MR <i>et al</i>., Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update, Endocrine Reviews, 2019, Volume 40, Issue 1, Pages 268–332<sup><a href="#ref-13">13</a></sup> by permission of the Endocrine Society.</p></div></div></div><p class="" id=d39561e2031>Changing long-acting release (LAR) octreotide to pasireotide LAR did not improve QoL even if further disease control was obtained<sup><a href="#ref-122">122</a></sup>. On the contrary, in one study, adding pegvisomant to SRLs led to improvement of QoL and clinical symptoms despite not showing any change in circulating IGF-1<sup><a href="#ref-124">124</a>,<a href="#ref-128">128</a></sup>, but studies with a similar design were negative<sup><a href="#ref-125">125</a>,<a href="#ref-129">129</a></sup>. This might suggest that improving biochemical control with a favorable safety profile and ease of administration would improve patient QoL. However, further research is required in this area.</p><p class="" id=d39561e2053>Radiotherapy is usually indicated for patients with more aggressive cases of acromegaly, in particular those with residual disease after surgery and medical therapy<sup><a href="#ref-75">75</a></sup>. Patients who underwent radiotherapy reported that it had a negative influence on energy, pain, social isolation, physical fatigue, and activity and motivation measured with the MFI-20<sup><a href="#ref-130">130</a></sup>. During follow-up, the scores in 5 out of 26 QoL subscales significantly worsened<sup><a href="#ref-75">75</a>,<a href="#ref-90">90</a></sup>. This might be due to a direct brain effect induced by radiotherapy, by new hormonal deficits, by delay in biochemical control of excess GH, or by the disease severity itself or by a combination of these factors. Nonetheless, the results are important to take in account in the decision to irradiate a tumor, especially in young patients.</p></div><div class=section><a name=d39561e2072 class=n-a></a><h3 class=section-title>Quality of life in acromegaly patients who become growth hormone–deficient after treatment</h3><p class="" id=d39561e2077>Development of GH deficiency after treatment of acromegaly has also been shown to affect QoL. Wexler <i>et al</i>. found that the mean scores on the Quality of Life Adult Growth Hormone Deficiency Assessment (QoL-AGHDA), SF-36, and Symptom Questionnaire Depression showed significantly impaired QoL in the GH-deficient group when compared with the GH-sufficient group. Peak GH levels after GH-releasing hormone-arginine stimulation were inversely associated with QoL-AGHDA scale scores (R = −0.53; <i>P</i> = 0.0005) and Symptom Questionnaire Depression subscale scores (R = −0.35; <i>P</i> = 0.031)<sup><a href="#ref-131">131</a></sup>.</p></div><div class=section><a name=d39561e2094 class=n-a></a><h3 class=section-title>Acromegaly-related pain and quality of life</h3><p class="" id=d39561e2099>Osteoarthritis is a major cause of pain in acromegaly. Although improvement of hypertrophic articular and periarticular tissues has been noted with normalization of GH/IGF-1,<sup><a href="#ref-132">132</a></sup> degenerative joint disease is somewhat irreversible, and arthralgias might not resolve even after biochemical remission<sup><a href="#ref-133">133</a>–<a href="#ref-135">135</a></sup>. Fifty-eight patients with acromegaly were evaluated with the SF-36, Arthritis Impact Measurement Scales 2 (AIMS2), and AcroQoL questionnaires; 52 (90%) reported musculoskeletal pain, 29 (50%) reported neck pain, 49 (84%) had hip osteoarthritis, and 20 (34%) reported knee osteoarthritis. The SF-36, AIMS2, and AcroQoL scores were lower in patients with musculoskeletal pain. The conclusion was that patients with acromegaly had a significantly higher number of musculoskeletal problems that negatively affect their QoL at different levels<sup><a href="#ref-136">136</a></sup>. Female patients and those with higher BMI seem to be the most affected<sup><a href="#ref-137">137</a></sup>. In regard to vertebral fractures, no definite association has been observed with QoL; this is probably because many events are asymptomatic and many are missed unless patients had vertebral x-ray rather than bone densitometry<sup><a href="#ref-138">138</a></sup>.</p></div><div class=section><a name=d39561e2126 class=n-a></a><h3 class=section-title>Management</h3><p class="" id=d39561e2131>QoL is an important treatment objective besides biochemical remission and tumor control. Close attention to patient perception of wellness is essential and should prompt treatment modifications. Use of specific questionnaires helps to identify areas of improvement and monitor therapy effects. Other interventions such as cognitive behavioral therapy with a technique called “Think healthy and feel the difference” have proven sustained improvement over 9 months. <sup><a href="#ref-139">139</a></sup> Moreover, physical activity programs<sup><a href="#ref-140">140</a></sup>, and increased knowledge about the disease from physician-guided discussion groups or patient associations may also help to improve patient’s QoL<sup><a href="#ref-141">141</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39561e2150>Conclusions</h2><p class="" id=d39561e2153>Recent population studies showed a longer life span for patients with acromegaly; this was most likely due to improvements in treatments, as the average delay in diagnosis seems to be largely unchanged over the decades. Raising awareness of complications of acromegaly even in biochemically controlled disease and introducing adequate screening programs in accordance with Acromegaly Consensus guidelines<sup><a href="#ref-10">10</a>,<a href="#ref-74">74</a></sup> should improve both morbidity and mortality. Patient-reported outcome and QoL have become essential components of monitoring the disease, and improving QoL is an endpoint of the treatment in itself. Although many questionnaires and scales have been developed, more research is needed to determine how best to measure QoL in patients with pituitary disease in general and with acromegaly in particular.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d39561e2167 class=n-a></a><h2 class=main-title id=d39561e2169>Acknowledgments</h2><p class="" id=d39561e2172>The authors thank Shirley McCartney, PhD (Oregon Health &amp; Sciences University Portland, Oregon, USA) for editorial assistance.</p></div><div class=back-section><a name=d39561e2176 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class=faculty-opinion-icon></span><span class="prime-red big">Faculty Opinions recommended</span></span><h2 class=main-title id=d40440>References</h2><div class="section ref-list"><a name=d39561e2176 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d39561e2183 class=n-a></a>Melmed S: Acromegaly pathogenesis and treatment. <i>J Clin Invest.</i> 2009; <b>119</b>(11): 3189–202. <a target=xrefwindow id=d39561e2191 href="http://www.ncbi.nlm.nih.gov/pubmed/19884662">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2194 href="https://doi.org/10.1172/JCI39375">Publisher Full Text </a> | <a target=xrefwindow id=d39561e2197 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2769196">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d39561e2206 class=n-a></a>Pivonello R, Auriemma RS, Grasso LFS, <i> et al.</i>: Complications of acromegaly: Cardiovascular, respiratory and metabolic comorbidities. <i>Pituitary.</i> 2017; <b>20</b>(1): 46–62. <a target=xrefwindow id=d39561e2217 href="http://www.ncbi.nlm.nih.gov/pubmed/28224405">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2220 href="https://doi.org/10.1007/s11102-017-0797-7">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d39561e2229 class=n-a></a>Petrossians P, Tichomirowa MA, Stevenaert A, <i> et al.</i>: The Liege Acromegaly Survey (LAS): A new software tool for the study of acromegaly. <i>Ann Endocrinol (Paris).</i> 2012; <b>73</b>(3): 190–201. <a target=xrefwindow id=d39561e2240 href="http://www.ncbi.nlm.nih.gov/pubmed/22682917">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2243 href="https://doi.org/10.1016/j.ando.2012.05.001">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d39561e2252 class=n-a></a>Terzolo M, Reimondo G, Berchialla P, <i> et al.</i>: Acromegaly is associated with increased cancer risk: A survey in Italy. <i>Endocr Relat Cancer.</i> 2017; <b>24</b>(9): 495–504. <a target=xrefwindow id=d39561e2263 href="http://www.ncbi.nlm.nih.gov/pubmed/28710115">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2266 href="https://doi.org/10.1530/ERC-16-0553">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/732763512"><span class="faculty-opinion-icon small"></span></a><a name=d39561e2275 class=n-a></a>Esposito D, Ragnarsson O, Granfeldt D, <i> et al.</i>: Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study. <i>Eur J Endocrinol.</i> 2018; <b>178</b>(5): 459–69. <a target=xrefwindow id=d39561e2286 href="http://www.ncbi.nlm.nih.gov/pubmed/29483205">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2289 href="https://doi.org/10.1530/EJE-18-0015">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/732763512">Faculty Opinions Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736538681"><span class="faculty-opinion-icon small"></span></a><a name=d39561e2303 class=n-a></a>Dagenais GR, Leong DP, Rangarajan S, <i> et al.</i>: Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): A prospective cohort study. <i>Lancet.</i> 2020; <b>395</b>(10226): 785–94. <a target=xrefwindow id=d39561e2314 href="http://www.ncbi.nlm.nih.gov/pubmed/31492501">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2317 href="https://doi.org/10.1016/S0140-6736(19)32007-0">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736538681">Faculty Opinions Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/733248989"><span class="faculty-opinion-icon small"></span></a><a name=d39561e2330 class=n-a></a>Bolfi F, Neves AF, Boguszewski CL, <i> et al.</i>: Mortality in acromegaly decreased in the last decade: A systematic review and meta-analysis. <i>Eur J Endocrinol.</i> 2018; <b>179</b>(1): 59–71. <a target=xrefwindow id=d39561e2341 href="http://www.ncbi.nlm.nih.gov/pubmed/29764907">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2344 href="https://doi.org/10.1530/EJE-18-0255">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/733248989">Faculty Opinions Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d39561e2357 class=n-a></a>Giustina A, Casanueva FF, Cavagnini F, <i> et al.</i>: Diagnosis and treatment of acromegaly complications. <i>J Endocrinol Invest.</i> 2003; <b>26</b>(12): 1242–7. <a target=xrefwindow id=d39561e2368 href="http://www.ncbi.nlm.nih.gov/pubmed/15055479">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2371 href="https://doi.org/10.1007/BF03349164">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/733036604"><span class="faculty-opinion-icon small"></span></a><a name=d39561e2380 class=n-a></a>Kunzler LS, Naves LA, Casulari LA: Cognitive-behavioral therapy improves the quality of life of patients with acromegaly. <i>Pituitary.</i> 2018; <b>21</b>(3): 323–33. <a target=xrefwindow id=d39561e2388 href="http://www.ncbi.nlm.nih.gov/pubmed/29644512">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2391 href="https://doi.org/10.1007/s11102-018-0887-1">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/733036604">Faculty Opinions Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d39561e2404 class=n-a></a>Bonadonna S, Doga M, Gola M, <i> et al.</i>: Diagnosis and treatment of acromegaly and its complications: Consensus guidelines. <i>J Endocrinol Invest.</i> 2005; <b>28</b>(11 Suppl International): 43–7. <a target=xrefwindow id=d39561e2415 href="http://www.ncbi.nlm.nih.gov/pubmed/16625844">PubMed Abstract </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d39561e2424 class=n-a></a>Weiss V, Šonka K, Pretl M, <i> et al.</i>: Prevalence of the sleep apnea syndrome in acromegaly population. <i>J Endocrinol Invest.</i> 2000; <b>23</b>(8): 515–9. <a target=xrefwindow id=d39561e2435 href="http://www.ncbi.nlm.nih.gov/pubmed/11021767">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2438 href="https://doi.org/10.1007/BF03343767">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d39561e2448 class=n-a></a>Webb SM, Badia X: Quality of Life in Acromegaly. <i>Neuroendocrinology.</i> 2016; <b>103</b>(1): 106–11. <a target=xrefwindow id=d39561e2456 href="http://www.ncbi.nlm.nih.gov/pubmed/25661974">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2459 href="https://doi.org/10.1159/000375451">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d39561e2468 class=n-a></a>Gadelha MR, Kasuki L, Lim DST, <i> et al.</i>: Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update. <i>Endocr Rev.</i> 2019; <b>40</b>(1): 268–332. <a target=xrefwindow id=d39561e2479 href="http://www.ncbi.nlm.nih.gov/pubmed/30184064">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2482 href="https://doi.org/10.1210/er.2018-00115">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d39561e2491 class=n-a></a>Colao A, Ferone D, Marzullo P, <i> et al.</i>: Systemic complications of acromegaly: Epidemiology, pathogenesis, and management. <i>Endocr Rev.</i> 2004; <b>25</b>(1): 102–52. <a target=xrefwindow id=d39561e2502 href="http://www.ncbi.nlm.nih.gov/pubmed/14769829">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2505 href="https://doi.org/10.1210/er.2002-0022">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d39561e2514 class=n-a></a>Dal J, Feldt-Rasmussen U, Andersen M, <i> et al.</i>: Acromegaly incidence, prevalence, complications and long-term prognosis: A nationwide cohort study. <i>Eur J Endocrinol.</i> 2016; <b>175</b>(3): 181–90. <a target=xrefwindow id=d39561e2525 href="http://www.ncbi.nlm.nih.gov/pubmed/27280374">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2528 href="https://doi.org/10.1530/EJE-16-0117">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d39561e2537 class=n-a></a>Chemla D, Attal P, Maione L, <i> et al.</i>: Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea. <i>J Clin Endocrinol Metab.</i> 2014; <b>99</b>(8): 2925–31. <a target=xrefwindow id=d39561e2548 href="http://www.ncbi.nlm.nih.gov/pubmed/24780045">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2551 href="https://doi.org/10.1210/jc.2013-4288">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d39561e2560 class=n-a></a>Vannucci L, Luciani P, Gagliardi E, <i> et al.</i>: Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters. <i>J Endocrinol Invest.</i> 2013; <b>36</b>(4): 237–42. <a target=xrefwindow id=d39561e2571 href="http://www.ncbi.nlm.nih.gov/pubmed/22776855">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2574 href="https://doi.org/10.3275/8513">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d39561e2584 class=n-a></a>Powlson AS, Gurnell M: Cardiovascular Disease and Sleep-Disordered Breathing in Acromegaly. <i>Neuroendocrinology.</i> 2016; <b>103</b>(1): 75–85. <a target=xrefwindow id=d39561e2592 href="http://www.ncbi.nlm.nih.gov/pubmed/26227953">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2595 href="https://doi.org/10.1159/000438903">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d39561e2604 class=n-a></a>Giustina A, Boni E, Romanelli G, <i> et al.</i>: Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. <i>Am J Cardiol.</i> 1995; <b>75</b>(15): 1042–7. <a target=xrefwindow id=d39561e2615 href="http://www.ncbi.nlm.nih.gov/pubmed/7747686">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2618 href="https://doi.org/10.1016/s0002-9149(99)80721-8">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d39561e2627 class=n-a></a>Thomas SG, Woodhouse LJ, Pagura SM, <i> et al.</i>: Ventilation threshold as a measure of impaired physical performance in adults with growth hormone excess. <i>Clin Endocrinol (Oxf).</i> 2002; <b>56</b>(3): 351–8. <a target=xrefwindow id=d39561e2638 href="http://www.ncbi.nlm.nih.gov/pubmed/11940047">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2641 href="https://doi.org/10.1046/j.1365-2265.2002.01476.x">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d39561e2650 class=n-a></a>Yilmaz F, Ozyildirim S, Talay F, <i> et al.</i>: Obstructive sleep apnea: a risk factor for cardiovascular disease. <i>Cardiol J.</i> 2007; <b>14</b>(2): 534–7. <a target=xrefwindow id=d39561e2661 href="http://www.ncbi.nlm.nih.gov/pubmed/21076317">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2664 href="https://doi.org/10.1097/JCN.0b013e3181e3d724">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d39561e2673 class=n-a></a>Yaggi HK, Mittleman MA, Bravata DM, <i> et al.</i>: Reducing cardiovascular risk through treatment of obstructive sleep apnea: 2 methodological approaches. <i>Am Heart J.</i> 2016; <b>172</b>: 135–43. <a target=xrefwindow id=d39561e2684 href="http://www.ncbi.nlm.nih.gov/pubmed/26856225">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2687 href="https://doi.org/10.1016/j.ahj.2015.07.033">Publisher Full Text </a> | <a target=xrefwindow id=d39561e2691 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4748381">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d39561e2700 class=n-a></a>Wang X, Ouyang Y, Wang Z, <i> et al.</i>: Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: A meta-analysis of prospective cohort studies. <i>Int J Cardiol.</i> 2013; <b>169</b>(3): 207–14. <a target=xrefwindow id=d39561e2711 href="http://www.ncbi.nlm.nih.gov/pubmed/24161531">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2714 href="https://doi.org/10.1016/j.ijcard.2013.08.088">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d39561e2724 class=n-a></a>Maione L, Brue T, Beckers A, <i> et al.</i>: Changes in the management and comorbidities of acromegaly over three decades: The French Acromegaly Registry. <i>Eur J Endocrinol.</i> 2017; <b>176</b>(5): 645–55. <a target=xrefwindow id=d39561e2735 href="http://www.ncbi.nlm.nih.gov/pubmed/28246150">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2738 href="https://doi.org/10.1530/EJE-16-1064">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/726361656"><span class="faculty-opinion-icon small"></span></a><a name=d39561e2747 class=n-a></a>Ritvonen E, Löyttyniemi E, Jaatinen P, <i> et al.</i>: Mortality in acromegaly: A 20-year follow-up study. <i>Endocr Relat Cancer.</i> 2016; <b>23</b>(6): 469–80. <a target=xrefwindow id=d39561e2758 href="http://www.ncbi.nlm.nih.gov/pubmed/27185871">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2761 href="https://doi.org/10.1530/ERC-16-0106">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/726361656">Faculty Opinions Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d39561e2774 class=n-a></a>Brody JS, Fisher AB, Gocmen A, <i> et al.</i>: Acromegalic pneumonomegaly: Lung growth in the adult. <i>J Clin Invest.</i> 1970; <b>49</b>(6): 1051–60. <a target=xrefwindow id=d39561e2785 href="http://www.ncbi.nlm.nih.gov/pubmed/5422011">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2788 href="https://doi.org/10.1172/JCI106321">Publisher Full Text </a> | <a target=xrefwindow id=d39561e2792 href="http://www.ncbi.nlm.nih.gov/pmc/articles/322573">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d39561e2801 class=n-a></a>Benfante A, Ciresi A, Bellia M, <i> et al.</i>: Early lung function abnormalities in acromegaly. <i>Lung.</i> 2015; <b>193</b>(3): 393–9. <a target=xrefwindow id=d39561e2812 href="http://www.ncbi.nlm.nih.gov/pubmed/25757541">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2815 href="https://doi.org/10.1007/s00408-015-9710-1">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d39561e2824 class=n-a></a>Murrant NJ, Gatland DJ: Respiratory problems in acromegaly. <i>J Laryngol Otol.</i> 1990; <b>104</b>(1): 52–5. <a target=xrefwindow id=d39561e2832 href="http://www.ncbi.nlm.nih.gov/pubmed/2313180">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2835 href="https://doi.org/10.1017/s0022215100111806">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/11421956"><span class="faculty-opinion-icon small"></span></a><a name=d39561e2844 class=n-a></a>Kamenicky P, Blanchard A, Frank M, <i> et al.</i>: Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity. <i>J Clin Endocrinol Metab.</i> 2011; <b>96</b>(7): 2127–35. <a target=xrefwindow id=d39561e2855 href="http://www.ncbi.nlm.nih.gov/pubmed/21508131">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2858 href="https://doi.org/10.1210/jc.2011-0078">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/11421956">Faculty Opinions Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d39561e2872 class=n-a></a>Kamenický P, Mazziotti G, Lombès M, <i> et al.</i>: Growth hormone, insulin-like growth factor-1, and the kidney: Pathophysiological and clinical implications. <i>Endocr Rev.</i> 2014; <b>35</b>(2): 234–81. <a target=xrefwindow id=d39561e2883 href="http://www.ncbi.nlm.nih.gov/pubmed/24423979">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2886 href="https://doi.org/10.1210/er.2013-1071">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d39561e2895 class=n-a></a>Camilo GB, Carvalho ARS, Guimarães ARM, <i> et al.</i>: Computed tomography airway lumen volumetry in patients with acromegaly: Association with growth hormone levels and lung function. <i>J Med Imaging Radiat Oncol.</i> 2017; <b>61</b>(5): 591–9. <a target=xrefwindow id=d39561e2906 href="http://www.ncbi.nlm.nih.gov/pubmed/28217888">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2909 href="https://doi.org/10.1111/1754-9485.12598 ">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d39561e2918 class=n-a></a>Lobie PE, García-Aragón J, <i> et al.</i>: Cellular localization of the growth hormone binding protein in the rat. <i>Endocrinology.</i> 1992; <b>130</b>(5): 3057–65. <a target=xrefwindow id=d39561e2929 href="http://www.ncbi.nlm.nih.gov/pubmed/1374020">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2932 href="https://doi.org/10.1210/endo.130.5.1374020">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d39561e2941 class=n-a></a>Noveral JP, Bhala A, Hintz RL, <i> et al.</i>: Insulin-like growth factor axis in airway smooth muscle cells. <i>Am J Physiol.</i> 1994; <b>267</b>(6 Pt 1): L761–L765. <a target=xrefwindow id=d39561e2952 href="http://www.ncbi.nlm.nih.gov/pubmed/7528983">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2955 href="https://doi.org/10.1152/ajplung.1994.267.6.L761">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d39561e2964 class=n-a></a>Donnelly PM, Grunstein RR, Peat JK, <i> et al.</i>: Large lungs and growth hormone: An increased alveolar number? <i>Eur Respir J.</i> 1995; <b>8</b>(6): 938–47. <a target=xrefwindow id=d39561e2975 href="http://www.ncbi.nlm.nih.gov/pubmed/7589380">PubMed Abstract </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d39561e2984 class=n-a></a>Evans CC, Hipkin LJ, Murray GM: Pulmonary function in acromegaly. <i>Thorax.</i> 1977; <b>32</b>(3): 322–7. <a target=xrefwindow id=d39561e2992 href="http://www.ncbi.nlm.nih.gov/pubmed/882947">PubMed Abstract </a> | <a target=xrefwindow id=d39561e2995 href="https://doi.org/10.1136/thx.32.3.322">Publisher Full Text </a> | <a target=xrefwindow id=d39561e2998 href="http://www.ncbi.nlm.nih.gov/pmc/articles/470609">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d39561e3008 class=n-a></a>Camilo GB, Carvalho ARS, Machado DC, <i> et al.</i>: Correlations between forced oscillation technique parameters and pulmonary densitovolumetry values in patients with acromegaly. <i>Braz J Med Biol Res.</i> 2015; <b>48</b>(10): 877–85. <a target=xrefwindow id=d39561e3019 href="http://www.ncbi.nlm.nih.gov/pubmed/26445330">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3022 href="https://doi.org/10.1590/1414-431X20154786">Publisher Full Text </a> | <a target=xrefwindow id=d39561e3026 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4617113">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d39561e3035 class=n-a></a>Camilo GB, Carvalho ARS, Machado DC, <i> et al.</i>: CT pulmonary densitovolumetry in patients with acromegaly: A comparison between active disease and controlled disease. <i>Br J Radiol.</i> 2015; <b>88</b>(1054): 20150315. <a target=xrefwindow id=d39561e3046 href="http://www.ncbi.nlm.nih.gov/pubmed/26246281">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3049 href="https://doi.org/10.1259/bjr.20150315">Publisher Full Text </a> | <a target=xrefwindow id=d39561e3053 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4738108">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d39561e3062 class=n-a></a>Camilo GB, Guimarães FS, Silva DPG, <i> et al.</i>: Pulmonary function testing and chest tomography in patients with acromegaly. <i>Multidiscip Respir Med.</i> 2013; <b>8</b>(1): 70. <a target=xrefwindow id=d39561e3073 href="http://www.ncbi.nlm.nih.gov/pubmed/24219873">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3076 href="https://doi.org/10.1186/2049-6958-8-70">Publisher Full Text </a> | <a target=xrefwindow id=d39561e3080 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3831601">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/732592653"><span class="faculty-opinion-icon small"></span></a><a name=d39561e3089 class=n-a></a>Zhang Z, Li Q, He W, <i> et al.</i>: The comprehensive impact on human body induced by resolution of growth hormone excess. <i>Eur J Endocrinol.</i> 2018; <b>178</b>(4): 365–75. <a target=xrefwindow id=d39561e3100 href="http://www.ncbi.nlm.nih.gov/pubmed/29386229">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3103 href="https://doi.org/10.1530/EJE-17-0872">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/732592653">Faculty Opinions Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d39561e3116 class=n-a></a>Mastaglia FL, Barwick DD, Hall R: Myopathy in Acromegaly. <i>Lancet.</i> 1970; <b>2</b>(7679): 907–9. <a target=xrefwindow id=d39561e3124 href="http://www.ncbi.nlm.nih.gov/pubmed/4097284">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3127 href="https://doi.org/10.1016/s0140-6736(70)92072-6">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d39561e3136 class=n-a></a>Khaleeli AA, Levy RD, Edwards RH, <i> et al.</i>: The neuromuscular features of acromegaly: A clinical and pathological study. <i>J Neurol Neurosurg Psychiatry.</i> 1984; <b>47</b>(9): 1009–15. <a target=xrefwindow id=d39561e3147 href="http://www.ncbi.nlm.nih.gov/pubmed/6481369">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3150 href="https://doi.org/10.1136/jnnp.47.9.1009">Publisher Full Text </a> | <a target=xrefwindow id=d39561e3154 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1028006">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d39561e3164 class=n-a></a>Attal P, Claes V, Bobin S, <i> et al.</i>: Growth hormone excess and sternohyoid muscle mechanics in rats. <i>Eur Respir J.</i> 2009; <b>34</b>(4): 967–74. <a target=xrefwindow id=d39561e3175 href="http://www.ncbi.nlm.nih.gov/pubmed/19357144">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3178 href="https://doi.org/10.1183/09031936.00171808">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d39561e3187 class=n-a></a>García-Río F, Pino JM, <i> et al.</i>: Reduction of Lung Distensibility in Acromegaly after Suppression of Growth Hormone Hypersecretion. <i>Am J Respir Crit Care Med.</i> 2001; <b>164</b>(5): 852–7. <a target=xrefwindow id=d39561e3198 href="http://www.ncbi.nlm.nih.gov/pubmed/11549545">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3201 href="https://doi.org/10.1164/ajrccm.164.5.2005059">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d39561e3210 class=n-a></a>Trotman-Dickenson B, Weetman AP, Hughes JM: Upper airflow obstruction and pulmonary function in acromegaly: Relationship to disease activity. <i>Q J Med.</i> 1991; <b>79</b>(290): 527–38. <a target=xrefwindow id=d39561e3218 href="http://www.ncbi.nlm.nih.gov/pubmed/1946933">PubMed Abstract </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d39561e3227 class=n-a></a>Yalin AS SS, Temizkan S, Gunes M, <i> et al.</i>: Evaluation of respiratory function in acromegalic patient. <i>Endocrine Abstracts</i>. 2010; <b>22</b>: 410. <a target=xrefwindow id=d39561e3238 href="https://www.endocrine-abstracts.org/ea/0022/ea0022p410">Reference Source</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d39561e3247 class=n-a></a>Saler T, Ucak S, Yesim T, <i> et al.</i>: Diffusing Lung Capacity of Carbon Monoxide/Alveolar Volume as an Index for Evaluating Diffusing Capacity of the Acromegalic Lung. <i>The Endocrinologist.</i> 2009; <b>19</b>(6): 288–90. <a target=xrefwindow id=d39561e3258 href="https://doi.org/10.1097/TEN.0b013e3181c08648">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d39561e3267 class=n-a></a>Gläser S, Friedrich N, Ewert R, <i> et al.</i>: Association between serum insulin-like growth factor (IGF) I and IGF binding protein-3 and lung function. <i>J Clin Endocrinol Metab.</i> 2009; <b>94</b>(7): 2452–8. <a target=xrefwindow id=d39561e3278 href="http://www.ncbi.nlm.nih.gov/pubmed/19401363">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3281 href="https://doi.org/10.1210/jc.2008-2662">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d39561e3291 class=n-a></a>Siafakas NM, Sigalas J, Filaditaki B, <i> et al.</i>: Small airway function in acromegaly. <i>Bull Eur Physiopathol Respir.</i> 1987; <b>23</b>(4): 329–34. <a target=xrefwindow id=d39561e3302 href="http://www.ncbi.nlm.nih.gov/pubmed/3690020">PubMed Abstract </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d39561e3311 class=n-a></a>Rodrigues MP, Naves LA, Viegas CA, <i> et al.</i>: Prevalence of lung structure abnormalities in patients with acromegaly and their relationship with gas exchange: Cross-sectional analytical study with a control group. <i>Sao Paulo Med J.</i> 2015; <b>133</b>(5): 394–400. <a target=xrefwindow id=d39561e3322 href="http://www.ncbi.nlm.nih.gov/pubmed/26648427">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3325 href="https://doi.org/10.1590/1516-3180.2013.7640012">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735522935"><span class="faculty-opinion-icon small"></span></a><a name=d39561e3334 class=n-a></a>Veasey SC, Rosen IM: Obstructive Sleep Apnea in Adults. <i>N Engl J Med.</i> 2019; <b>380</b>(15): 1442–9. <a target=xrefwindow id=d39561e3342 href="http://www.ncbi.nlm.nih.gov/pubmed/30970189">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3345 href="https://doi.org/10.1056/NEJMcp1816152">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735522935">Faculty Opinions Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d39561e3358 class=n-a></a>Saaresranta T, Polo O: Hormones and breathing. <i>Chest.</i> 2002; <b>122</b>(6): 2165–82. <a target=xrefwindow id=d39561e3366 href="http://www.ncbi.nlm.nih.gov/pubmed/12475861">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3369 href="https://doi.org/10.1378/chest.122.6.2165">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d39561e3378 class=n-a></a>Chanson P, Timsit J, Benoit O, <i> et al.</i>: Rapid Improvement in Sleep Apnoea of Acromegaly After Short-Term Treatment With Somatostatin Analogue SMS 201-995. <i>Lancet.</i> 1986; <b>327</b>(8492): 1270–1. <a target=xrefwindow id=d39561e3389 href="http://www.ncbi.nlm.nih.gov/pubmed/2872408">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3392 href="https://doi.org/10.1016/s0140-6736(86)91405-4">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d39561e3401 class=n-a></a>Grunstein RR, Ho KY, Sullivan CE: Sleep apnea in acromegaly. <i>Ann Intern Med.</i> 1991; <b>115</b>(7): 527–32. <a target=xrefwindow id=d39561e3409 href="http://www.ncbi.nlm.nih.gov/pubmed/1883121">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3412 href="https://doi.org/10.7326/0003-4819-115-7-527">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d39561e3422 class=n-a></a>Herrmann BL, Wessendorf TE, Ajaj W, <i> et al.</i>: Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. <i>Eur J Endocrinol.</i> 2004; <b>151</b>(3): 309–15. <a target=xrefwindow id=d39561e3433 href="http://www.ncbi.nlm.nih.gov/pubmed/15362959">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3436 href="https://doi.org/10.1530/eje.0.1510309">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736758466"><span class="faculty-opinion-icon small"></span></a><a name=d39561e3445 class=n-a></a>Wolters TLC, Roerink SHPP, Drenthen LCA, <i> et al.</i>: The Course of Obstructive Sleep Apnea Syndrome in Patients With Acromegaly During Treatment. <i>J Clin Endocrinol Metab.</i> 2020; <b>105</b>(1): dgz050. <a target=xrefwindow id=d39561e3456 href="http://www.ncbi.nlm.nih.gov/pubmed/31612224">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3459 href="https://doi.org/10.1210/clinem/dgz050">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736758466">Faculty Opinions Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d39561e3472 class=n-a></a>Grunstein RR, Ho KY, Berthon-Jones M, <i> et al.</i>: Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. <i>Am J Respir Crit Care Med.</i> 1994; <b>150</b>(2): 496–502. <a target=xrefwindow id=d39561e3483 href="http://www.ncbi.nlm.nih.gov/pubmed/8049836">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3486 href="https://doi.org/10.1164/ajrccm.150.2.8049836">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/737010300"><span class="faculty-opinion-icon small"></span></a><a name=d39561e3495 class=n-a></a>Chennaoui M, Léger D, Gomez-Merino D: Sleep and the GH/IGF-1 axis: Consequences and countermeasures of sleep loss/disorders. <i>Sleep Med Rev.</i> 2020; <b>49</b>: 101223. <a target=xrefwindow id=d39561e3503 href="http://www.ncbi.nlm.nih.gov/pubmed/31778943">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3506 href="https://doi.org/10.1016/j.smrv.2019.101223">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/737010300">Faculty Opinions Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/732878989"><span class="faculty-opinion-icon small"></span></a><a name=d39561e3519 class=n-a></a>Bhasin S, Brito JP, Cunningham GR, <i> et al.</i>: Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. <i>J Clin Endocrinol Metab.</i> 2018; <b>103</b>(5): 1715–44. <a target=xrefwindow id=d39561e3530 href="http://www.ncbi.nlm.nih.gov/pubmed/29562364">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3533 href="https://doi.org/10.1210/jc.2018-00229">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/732878989">Faculty Opinions Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d39561e3546 class=n-a></a>Attal P, Chanson P, <i> et al.</i>: Endocrine aspects of obstructive sleep apnea. <i>J Clin Endocrinol Metab.</i> 2010; <b>95</b>(2): 483–95. <a target=xrefwindow id=d39561e3557 href="http://www.ncbi.nlm.nih.gov/pubmed/20061419">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3560 href="https://doi.org/10.1210/jc.2009-1912">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736535648"><span class="faculty-opinion-icon small"></span></a><a name=d39561e3570 class=n-a></a>Wennberg A, Lorusso R, Dassie F, <i> et al.</i>: Sleep disorders and cognitive dysfunction in acromegaly. <i>Endocrine.</i> 2019; <b>66</b>(3): 634–641. <a target=xrefwindow id=d39561e3581 href="http://www.ncbi.nlm.nih.gov/pubmed/31473920">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3584 href="https://doi.org/10.1007/s12020-019-02061-1">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736535648">Faculty Opinions Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d39561e3597 class=n-a></a>Davì MV, Giustina A: Sleep apnea in acromegaly: A review on prevalence, pathogenetic aspects and treatment. <i>Expert Rev Endocrinol Metab.</i> 2012; <b>7</b>(1): 55–62. <a target=xrefwindow id=d39561e3605 href="http://www.ncbi.nlm.nih.gov/pubmed/30736111">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3608 href="https://doi.org/10.1586/eem.11.82">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d39561e3617 class=n-a></a>Pekkarinen T, Partinen M, Pelkonen R, <i> et al.</i>: Sleep Apnoea and Daytime Sleepiness in Acromegaly: Relationship to Endocrinological Factors. <i>Clin Endocrinol (Oxf).</i> 1987; <b>27</b>(6): 649–54. <a target=xrefwindow id=d39561e3628 href="http://www.ncbi.nlm.nih.gov/pubmed/3455370">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3631 href="https://doi.org/10.1111/j.1365-2265.1987.tb02947.x">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d39561e3640 class=n-a></a>Rosenow F, Reuter S, Deuss U, <i> et al.</i>: Sleep apnoea in treated acromegaly: Relative frequency and predisposing factors. <i>Clin Endocrinol (Oxf).</i> 1996; <b>45</b>(5): 563–9. <a target=xrefwindow id=d39561e3651 href="http://www.ncbi.nlm.nih.gov/pubmed/8977753">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3654 href="https://doi.org/10.1046/j.1365-2265.1996.00852.x">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/733749606"><span class="faculty-opinion-icon small"></span></a><a name=d39561e3663 class=n-a></a>Vouzouneraki K, Franklin KA, Forsgren M, <i> et al.</i>: Temporal relationship of sleep apnea and acromegaly: A nationwide study. <i>Endocrine.</i> 2018; <b>62</b>(2): 456–63. <a target=xrefwindow id=d39561e3674 href="http://www.ncbi.nlm.nih.gov/pubmed/30066288">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3677 href="https://doi.org/10.1007/s12020-018-1694-1">Publisher Full Text </a> | <a target=xrefwindow id=d39561e3681 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6208862">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/733749606">Faculty Opinions Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d39561e3694 class=n-a></a>Kapur VK, Auckley DH, Chowdhuri S, <i> et al.</i>: Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. <i>J Clin Sleep Med.</i> 2017; <b>13</b>(3): 479–504. <a target=xrefwindow id=d39561e3705 href="http://www.ncbi.nlm.nih.gov/pubmed/28162150">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3708 href="https://doi.org/10.5664/jcsm.6506">Publisher Full Text </a> | <a target=xrefwindow id=d39561e3712 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5337595">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d39561e3722 class=n-a></a>Roemmler J, Gutt B, Fischer R, <i> et al.</i>: Elevated incidence of sleep apnoea in acromegaly—correlation to disease activity. <i>Sleep Breath.</i> 2012; <b>16</b>(4): 1247–53. <a target=xrefwindow id=d39561e3733 href="http://www.ncbi.nlm.nih.gov/pubmed/22241151">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3736 href="https://doi.org/10.1007/s11325-011-0641-7">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d39561e3745 class=n-a></a>Störmann S, Gutt B, Roemmler-Zehrer J, <i> et al.</i>: Assessment of lung function in a large cohort of patients with acromegaly. <i>Eur J Endocrinol.</i> 2017; <b>177</b>(1): 15–23. <a target=xrefwindow id=d39561e3756 href="http://www.ncbi.nlm.nih.gov/pubmed/28432267">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3759 href="https://doi.org/10.1530/EJE-16-1080">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736905862"><span class="faculty-opinion-icon small"></span></a><a name=d39561e3768 class=n-a></a>Parolin M, Dassie F, Alessio L, <i> et al.</i>: Obstructive Sleep Apnea in Acromegaly and the Effect of Treatment: A Systematic Review and Meta-Analysis. <i>J Clin Endocrinol Metab.</i> 2020; <b>105</b>(3): dgz116. <a target=xrefwindow id=d39561e3779 href="http://www.ncbi.nlm.nih.gov/pubmed/31722411">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3782 href="https://doi.org/10.1210/clinem/dgz116">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736905862">Faculty Opinions Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d39561e3795 class=n-a></a>Berg C, Wessendorf TE, Mortsch F, <i> et al.</i>: Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly. <i>Eur J Endocrinol.</i> 2009; <b>161</b>(6): 829–35. <a target=xrefwindow id=d39561e3806 href="http://www.ncbi.nlm.nih.gov/pubmed/19773369">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3809 href="https://doi.org/10.1530/EJE-09-0694">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d39561e3818 class=n-a></a>Grunstein RR, Ho KK, Sullivan CE: Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. <i>Ann Intern Med.</i> 1994; <b>121</b>(7): 478–83. <a target=xrefwindow id=d39561e3826 href="http://www.ncbi.nlm.nih.gov/pubmed/8067645">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3829 href="https://doi.org/10.7326/0003-4819-121-7-199410010-00002">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d39561e3838 class=n-a></a>Al Lawati NM, Patel SR, Ayas NT: Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. <i>Prog Cardiovasc Dis.</i> 2009; <b>51</b>(4): 285–93. <a target=xrefwindow id=d39561e3846 href="http://www.ncbi.nlm.nih.gov/pubmed/19110130">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3849 href="https://doi.org/10.1016/j.pcad.2008.08.001">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/723730401"><span class="faculty-opinion-icon small"></span></a><a name=d39561e3859 class=n-a></a>Annamalai AK, Webb A, Kandasamy N, <i> et al.</i>: A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy. <i>J Clin Endocrinol Metab.</i> 2013; <b>98</b>(3): 1040–50. <a target=xrefwindow id=d39561e3870 href="http://www.ncbi.nlm.nih.gov/pubmed/23393175">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3873 href="https://doi.org/10.1210/jc.2012-3072">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/723730401">Faculty Opinions Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d39561e3886 class=n-a></a>Katznelson L, Laws ER Jr, Melmed S, <i> et al.</i>: Acromegaly: An endocrine society clinical practice guideline. <i>J Clin Endocrinol Metab.</i> 2014; <b>99</b>(11): 3933–51. <a target=xrefwindow id=d39561e3897 href="http://www.ncbi.nlm.nih.gov/pubmed/25356808">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3900 href="https://doi.org/10.1210/jc.2014-2700">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d39561e3909 class=n-a></a>Giustina A, Barkan A, Beckers A, <i> et al.</i>: A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update. <i>J Clin Endocrinol Metab.</i> 2020; <b>105</b>(4): dgz096. <a target=xrefwindow id=d39561e3920 href="http://www.ncbi.nlm.nih.gov/pubmed/31606735">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3923 href="https://doi.org/10.1210/clinem/dgz096">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d39561e3932 class=n-a></a>Badia X, Webb SM, Prieto L, <i> et al.</i>: Acromegaly Quality of Life Questionnaire (AcroQoL). <i>Health Qual Life Outcomes.</i> 2004; <b>2</b>: 13. <a target=xrefwindow id=d39561e3943 href="http://www.ncbi.nlm.nih.gov/pubmed/14987332">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3946 href="https://doi.org/10.1186/1477-7525-2-13">Publisher Full Text </a> | <a target=xrefwindow id=d39561e3950 href="http://www.ncbi.nlm.nih.gov/pmc/articles/404471">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/732148619"><span class="faculty-opinion-icon small"></span></a><a name=d39561e3959 class=n-a></a>Liu S, Adelman DT, Xu Y, <i> et al.</i>: Patient-centered assessment on disease burden, quality of life, and treatment satisfaction associated with acromegaly. <i>J Investig Med.</i> 2018; <b>66</b>(3): 653–60. <a target=xrefwindow id=d39561e3970 href="http://www.ncbi.nlm.nih.gov/pubmed/29151042">PubMed Abstract </a> | <a target=xrefwindow id=d39561e3973 href="https://doi.org/10.1136/jim-2017-000570">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/732148619">Faculty Opinions Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/11106956"><span class="faculty-opinion-icon small"></span></a><a name=d39561e3986 class=n-a></a>Ben-Shlomo A, Sheppard MC, Stephens JM, <i> et al.</i>: Clinical, quality of life, and economic value of acromegaly disease control. <i>Pituitary.</i> 2011; <b>14</b>(3): 284–94. <a target=xrefwindow id=d39561e3997 href="http://www.ncbi.nlm.nih.gov/pubmed/21597975">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4000 href="https://doi.org/10.1007/s11102-011-0310-7">Publisher Full Text </a> | <a target=xrefwindow id=d39561e4004 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3146976">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/11106956">Faculty Opinions Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d39561e4018 class=n-a></a>Cannavò S, Condurso R, Ragonese M, <i> et al.</i>: Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. <i>Pituitary.</i> 2011; <b>14</b>(4): 328–34. <a target=xrefwindow id=d39561e4029 href="http://www.ncbi.nlm.nih.gov/pubmed/21328081">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4032 href="https://doi.org/10.1007/s11102-011-0298-z">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d39561e4041 class=n-a></a>Yedinak CG, Fleseriu M: Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: A pilot study. <i>Endocrine.</i> 2014; <b>46</b>(3): 585–93. <a target=xrefwindow id=d39561e4049 href="http://www.ncbi.nlm.nih.gov/pubmed/24282035">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4052 href="https://doi.org/10.1007/s12020-013-0106-9">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/738325822"><span class="faculty-opinion-icon small"></span></a><a name=d39561e4061 class=n-a></a>Jawiarczyk-Przybyłowska A, Szcześniak D, Ciułkowicz M, <i> et al.</i>: Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly. <i>Front Endocrinol (Lausanne).</i> 2020; <b>10</b>: 899. <a target=xrefwindow id=d39561e4072 href="http://www.ncbi.nlm.nih.gov/pubmed/32010060">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4075 href="https://doi.org/10.3389/fendo.2019.00899">Publisher Full Text </a> | <a target=xrefwindow id=d39561e4079 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6972500">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/738325822">Faculty Opinions Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d39561e4092 class=n-a></a>Siegel S, Streetz-van der Werf C, Schott JS, <i> et al.</i>: Diagnostic delay is associated with psychosocial impairment in acromegaly. <i>Pituitary.</i> 2013; <b>16</b>(4): 507–14. <a target=xrefwindow id=d39561e4103 href="http://www.ncbi.nlm.nih.gov/pubmed/23179964">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4106 href="https://doi.org/10.1007/s11102-012-0447-z">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d39561e4115 class=n-a></a>Rowles SV, Prieto L, Badia X, <i> et al.</i>: Quality of Life (QOL) in Patients with Acromegaly Is Severely Impaired: Use of a Novel Measure of QOL: Acromegaly Quality of Life Questionnaire. <i>J Clin Endocrinol Metab.</i> 2005; <b>90</b>(6): 3337–41. <a target=xrefwindow id=d39561e4126 href="http://www.ncbi.nlm.nih.gov/pubmed/15755865">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4129 href="https://doi.org/10.1210/jc.2004-1565">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d39561e4138 class=n-a></a>Kellner R: A symptom questionnaire. <i>J Clin Psychiatry.</i> 1987; <b>48</b>(7): 268–74. <a target=xrefwindow id=d39561e4146 href="http://www.ncbi.nlm.nih.gov/pubmed/3597327">PubMed Abstract </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d39561e4156 class=n-a></a>Fava GA, Kellner R, Perini GI, <i> et al.</i>: Italian validation of the Symptom Rating Test (SRT) and Symptom Questionnaire (SQ). <i>Can J Psychiatry.</i> 1983; <b>28</b>(2): 117–23. <a target=xrefwindow id=d39561e4167 href="http://www.ncbi.nlm.nih.gov/pubmed/6839279">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4170 href="https://doi.org/10.1177/070674378302800208">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d39561e4179 class=n-a></a>Trainer PJ, Drake WM, Katznelson L, <i> et al.</i>: Treatment of Acromegaly with the Growth Hormone-Receptor Antagonist Pegvisomant. <i>N Engl J Med.</i> 2000; <b>342</b>(16): 1171–7. <a target=xrefwindow id=d39561e4190 href="http://www.ncbi.nlm.nih.gov/pubmed/10770982">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4193 href="https://doi.org/10.1056/NEJM200004203421604">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d39561e4202 class=n-a></a>van der Lely AJ, Hutson RK, Trainer PJ, <i> et al.</i>: Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. <i>Lancet.</i> 2001; <b>358</b>(9295): 1754–9. <a target=xrefwindow id=d39561e4213 href="http://www.ncbi.nlm.nih.gov/pubmed/11734231">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4216 href="https://doi.org/10.1016/s0140-6736(01)06844-1">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d39561e4225 class=n-a></a>McHorney CA, Ware Jr JE, Raczek AE: The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. <i>Med Care.</i> 1993; <b>31</b>(3): 247–63. <a target=xrefwindow id=d39561e4233 href="http://www.ncbi.nlm.nih.gov/pubmed/8450681">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4236 href="https://doi.org/10.1097/00005650-199303000-00006">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d39561e4245 class=n-a></a>McHorney CA, Ware JE Jr, Rachel Lu JF, <i> et al.</i>: The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups. <i>Med Care.</i> 1994; <b>32</b>(1): 40–66. <a target=xrefwindow id=d39561e4256 href="http://www.ncbi.nlm.nih.gov/pubmed/8277801">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4259 href="https://doi.org/10.1097/00005650-199401000-00004">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d39561e4268 class=n-a></a>Russo J, Trujillo CA, Wingerson D, <i> et al.</i>: The MOS 36-Item Short Form Health Survey: Reliability, validity, and preliminary findings in schizophrenic outpatients. <i>Med Care.</i> 1998; <b>36</b>(5): 752–6. <a target=xrefwindow id=d39561e4279 href="http://www.ncbi.nlm.nih.gov/pubmed/9596066">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4282 href="https://doi.org/10.1097/00005650-199805000-00015">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d39561e4292 class=n-a></a>van der Klaauw AA, Kars M, Biermasz NR, <i> et al.</i>: Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. <i>Clin Endocrinol (Oxf).</i> 2008; <b>69</b>(5): 775–84. <a target=xrefwindow id=d39561e4303 href="http://www.ncbi.nlm.nih.gov/pubmed/18462264">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4306 href="https://doi.org/10.1111/j.1365-2265.2008.03288.x">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d39561e4315 class=n-a></a>Smets EM, Garssen B, Bonke B, <i> et al.</i>: The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. <i>J Psychosom Res.</i> 1995; <b>39</b>(3): 315–25. <a target=xrefwindow id=d39561e4326 href="http://www.ncbi.nlm.nih.gov/pubmed/7636775">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4329 href="https://doi.org/10.1016/0022-3999(94)00125-o">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d39561e4338 class=n-a></a>Hunt SM, McKenna SP, McEwen J, <i> et al.</i>: A quantitative approach to perceived health status: A validation study. <i>J Epidemiol Community Health.</i> 1980; <b>34</b>(4): 281–6. <a target=xrefwindow id=d39561e4349 href="http://www.ncbi.nlm.nih.gov/pubmed/7241028">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4352 href="https://doi.org/10.1136/jech.34.4.281">Publisher Full Text </a> | <a target=xrefwindow id=d39561e4356 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1052092">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d39561e4365 class=n-a></a>Hunt SM, McKenna SP, McEwen J, <i> et al.</i>: The Nottingham health profile: Subjective health status and medical consultations. <i>Soc Sci Med A.</i> 1981; <b>15</b>(3 Pt 1): 221–9. <a target=xrefwindow id=d39561e4376 href="http://www.ncbi.nlm.nih.gov/pubmed/6973203">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4379 href="https://doi.org/10.1016/0271-7123(81)90005-5">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d39561e4388 class=n-a></a>Kauppinen-Mäkelin R, Sane T, Sintonen H, <i> et al.</i>: Quality of life in treated patients with acromegaly. <i>J Clin Endocrinol Metab.</i> 2006; <b>91</b>(10): 3891–6. <a target=xrefwindow id=d39561e4399 href="http://www.ncbi.nlm.nih.gov/pubmed/16849407">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4402 href="https://doi.org/10.1210/jc.2006-0676">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d39561e4411 class=n-a></a>Grossi E, Groth N, Mosconi P, <i> et al.</i>: Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S). <i>Health Qual Life Outcomes.</i> 2006; <b>4</b>: 88. <a target=xrefwindow id=d39561e4422 href="http://www.ncbi.nlm.nih.gov/pubmed/17105655">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4425 href="https://doi.org/10.1186/1477-7525-4-88">Publisher Full Text </a> | <a target=xrefwindow id=d39561e4429 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1647268">Free Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d39561e4439 class=n-a></a>Wassenaar MJE, Biermasz NR, Kloppenburg M, <i> et al.</i>: Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. <i>Growth Horm IGF Res.</i> 2010; <b>20</b>(3): 226–33. <a target=xrefwindow id=d39561e4450 href="http://www.ncbi.nlm.nih.gov/pubmed/20194043">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4453 href="https://doi.org/10.1016/j.ghir.2010.02.003">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d39561e4462 class=n-a></a>Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. <i>Acta Psychiatr Scand.</i> 1983; <b>67</b>(6): 361–70. <a target=xrefwindow id=d39561e4470 href="http://www.ncbi.nlm.nih.gov/pubmed/6880820">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4473 href="https://doi.org/10.1111/j.1600-0447.1983.tb09716.x">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d39561e4482 class=n-a></a>Webb SM, Badia X, Surinach NL, <i> et al.</i>: Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: A 6-month prospective study. <i>Eur J Endocrinol.</i> 2006; <b>155</b>(2): 269–77. <a target=xrefwindow id=d39561e4493 href="http://www.ncbi.nlm.nih.gov/pubmed/16868140">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4496 href="https://doi.org/10.1530/eje.1.02214">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d39561e4505 class=n-a></a>Fleseriu M, Fogelfeld L, Gordon MB, <i> et al.</i>: Development of a novel patient-reported measure for acromegaly: The Acro-TSQ. <i>Pituitary.</i> 2019; <b>22</b>(6): 581–93. <a target=xrefwindow id=d39561e4516 href="http://www.ncbi.nlm.nih.gov/pubmed/31522359">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4519 href="https://doi.org/10.1007/s11102-019-00986-4">Publisher Full Text </a> | <a target=xrefwindow id=d39561e4523 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6842345">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d39561e4532 class=n-a></a>Fleseriu M, Fogelfeld L, Gordon MB, <i> et al.</i>: An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: Data from two large multicenter international studies. <i>Pituitary.</i> 2020; <b>23</b>(4): 347–358. <a target=xrefwindow id=d39561e4543 href="http://www.ncbi.nlm.nih.gov/pubmed/32221764">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4546 href="https://doi.org/10.1007/s11102-020-01038-y">Publisher Full Text </a> | <a target=xrefwindow id=d39561e4550 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7316852">Free Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d39561e4559 class=n-a></a>Geraedts VJ, Andela CD, Stalla GK, <i> et al.</i>: Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters. <i>Front Endocrinol (Lausanne).</i> 2017; <b>8</b>: 40. <a target=xrefwindow id=d39561e4570 href="http://www.ncbi.nlm.nih.gov/pubmed/28316591">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4573 href="https://doi.org/10.3389/fendo.2017.00040">Publisher Full Text </a> | <a target=xrefwindow id=d39561e4577 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5334635">Free Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/737397747"><span class="faculty-opinion-icon small"></span></a><a name=d39561e4587 class=n-a></a>Lenders NF, McCormack AI, Ho KKY: MANAGEMENT OF ENDOCRINE DISEASE: Does gender matter in the management of acromegaly? <i>Eur J Endocrinol.</i> 2020; <b>182</b>(5): R67–R82. <a target=xrefwindow id=d39561e4595 href="http://www.ncbi.nlm.nih.gov/pubmed/32069216">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4598 href="https://doi.org/ 10.1530/EJE-19-1023">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/737397747">Faculty Opinions Recommendation</a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d39561e4611 class=n-a></a>Ambrosio MR, Gagliardi I, Chiloiro S, <i> et al.</i>: Acromegaly in the elderly patients. <i>Endocrine.</i> 2020; <b>68</b>(1): 16–31. <a target=xrefwindow id=d39561e4622 href="http://www.ncbi.nlm.nih.gov/pubmed/32060689">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4625 href="https://doi.org/10.1007/s12020-020-02206-7">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/737240839"><span class="faculty-opinion-icon small"></span></a><a name=d39561e4634 class=n-a></a>Wolters TLC, Roerink SHPP, Sterenborg RBTM, <i> et al.</i>: The effect of treatment on quality of life in patients with acromegaly: A prospective study. <i>Eur J Endocrinol.</i> 2020; <b>182</b>(3): 319–31. <a target=xrefwindow id=d39561e4645 href="http://www.ncbi.nlm.nih.gov/pubmed/31958318">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4648 href="https://doi.org/10.1530/EJE-19-0732">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/737240839">Faculty Opinions Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d39561e4661 class=n-a></a>Paisley AN, Rowles SV, Roberts ME, <i> et al.</i>: Treatment of acromegaly improves quality of life, measured by AcroQol. <i>Clin Endocrinol (Oxf).</i> 2007; <b>67</b>(3): 358–62. <a target=xrefwindow id=d39561e4672 href="http://www.ncbi.nlm.nih.gov/pubmed/17555502">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4675 href="https://doi.org/10.1111/j.1365-2265.2007.02891.x">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/738325827"><span class="faculty-opinion-icon small"></span></a><a name=d39561e4684 class=n-a></a>Tseng FY, Chen ST, Chen JF, <i> et al.</i>: Correlations of clinical parameters with quality of life in patients with acromegaly: Taiwan Acromegaly Registry. <i>J Formos Med Assoc.</i> 2019; <b>118</b>(11): 1488–93. <a target=xrefwindow id=d39561e4695 href="http://www.ncbi.nlm.nih.gov/pubmed/31147197">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4698 href="https://doi.org/10.1016/j.jfma.2019.05.007">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/738325827">Faculty Opinions Recommendation</a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d39561e4711 class=n-a></a>Trepp R, Everts R, Stettler C, <i> et al.</i>: Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL). <i>Clin Endocrinol (Oxf).</i> 2005; <b>63</b>(1): 103–10. <a target=xrefwindow id=d39561e4722 href="http://www.ncbi.nlm.nih.gov/pubmed/15963069">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4725 href="https://doi.org/10.1111/j.1365-2265.2005.02307.x">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d39561e4735 class=n-a></a>Biermasz NR, van Thiel SW, Pereira AM, <i> et al.</i>: Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. <i>J Clin Endocrinol Metab.</i> 2004; <b>89</b>(11): 5369–76. <a target=xrefwindow id=d39561e4746 href="http://www.ncbi.nlm.nih.gov/pubmed/15531483">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4749 href="https://doi.org/10.1210/jc.2004-0669">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d39561e4758 class=n-a></a>Biermasz NR, Pereira AM, Smit JWA, <i> et al.</i>: Morbidity after Long-Term Remission for Acromegaly: Persisting Joint-Related Complaints Cause Reduced Quality of Life. <i>J Clin Endocrinol Metab.</i> 2005; <b>90</b>(5): 2731–9. <a target=xrefwindow id=d39561e4769 href="http://www.ncbi.nlm.nih.gov/pubmed/15741257">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4772 href="https://doi.org/10.1210/jc.2004-2297">Publisher Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735730796"><span class="faculty-opinion-icon small"></span></a><a name=d39561e4781 class=n-a></a>Waddle MR, Oudenhoven MD, Farin CV, <i> et al.</i>: Impacts of Surgery on Symptom Burden and Quality of Life in Pituitary Tumor Patients in the Subacute Post-operative Period. <i>Front Oncol.</i> 2019; <b>9</b>: 299. <a target=xrefwindow id=d39561e4792 href="http://www.ncbi.nlm.nih.gov/pubmed/31065545">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4795 href="https://doi.org/10.3389/fonc.2019.00299">Publisher Full Text </a> | <a target=xrefwindow id=d39561e4799 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6489897">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735730796">Faculty Opinions Recommendation</a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d39561e4812 class=n-a></a>Matta MP, Couture E, Cazals L, <i> et al.</i>: Impaired quality of life of patients with acromegaly: Control of GH/IGF-I excess improves psychological subscale appearance. <i>Eur J Endocrinol.</i> 2008; <b>158</b>(3): 305–10. <a target=xrefwindow id=d39561e4823 href="http://www.ncbi.nlm.nih.gov/pubmed/18299462">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4826 href="https://doi.org/10.1530/EJE-07-0697">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d39561e4835 class=n-a></a>Rubeck KZ, Madsen M, Andreasen CM, <i> et al.</i>: Conventional and novel biomarkers of treatment outcome in patients with acromegaly: Discordant results after somatostatin analog treatment compared with surgery. <i>Eur J Endocrinol.</i> 2010; <b>163</b>(5): 717–26. <a target=xrefwindow id=d39561e4846 href="http://www.ncbi.nlm.nih.gov/pubmed/20813787">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4849 href="https://doi.org/10.1530/EJE-10-0640">Publisher Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d39561e4858 class=n-a></a>Sonino N, Scarpa E, Paoletta A, <i> et al.</i>: Slow-Release Lanreotide Treatment in Acromegaly: Effects on Quality of Life. <i>Psychother Psychosom.</i> 1999; <b>68</b>(3): 165–7. <a target=xrefwindow id=d39561e4869 href="http://www.ncbi.nlm.nih.gov/pubmed/10224516">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4872 href="https://doi.org/10.1159/000012326">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d39561e4882 class=n-a></a>Lombardi G, Minuto F, Tamburrano G, <i> et al.</i>: Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly. <i>J Endocrinol Invest.</i> 2009; <b>32</b>(3): 202–9. <a target=xrefwindow id=d39561e4893 href="http://www.ncbi.nlm.nih.gov/pubmed/19542735">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4896 href="https://doi.org/10.1007/BF03346453">Publisher Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d39561e4905 class=n-a></a>Caron PJ, Bevan JS, Petersenn S, <i> et al.</i>: Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: Data from the PRIMARYS study. <i>Pituitary.</i> 2016; <b>19</b>(2): 149–57. <a target=xrefwindow id=d39561e4916 href="http://www.ncbi.nlm.nih.gov/pubmed/26603536">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4919 href="https://doi.org/10.1007/s11102-015-0693-y">Publisher Full Text </a> | <a target=xrefwindow id=d39561e4923 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4799252">Free Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d39561e4932 class=n-a></a>Schopohl J, Strasburger CJ, Caird D, <i> et al.</i>: Efficacy and Acceptability of Lanreotide Autogel<sup>®</sup> 120 mg at Different Dose Intervals in Patients with Acromegaly Previously Treated with Octreotide LAR. <i>Exp Clin Endocrinol Diabetes.</i> 2011; <b>119</b>(3): 156–62. <a target=xrefwindow id=d39561e4946 href="http://www.ncbi.nlm.nih.gov/pubmed/21086246">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4950 href="https://doi.org/10.1055/s-0030-1267244">Publisher Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d39561e4959 class=n-a></a>Mangupli R, Camperos P, Webb SM: Biochemical and quality of life responses to octreotide-LAR in acromegaly. <i>Pituitary.</i> 2014; <b>17</b>(6): 495–9. <a target=xrefwindow id=d39561e4967 href="http://www.ncbi.nlm.nih.gov/pubmed/24178448">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4970 href="https://doi.org/10.1007/s11102-013-0533-x">Publisher Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d39561e4979 class=n-a></a>Chin SO, Chung CH, Chung YS, <i> et al.</i>: Change in quality of life in patients with acromegaly after treatment with octreotide LAR: First application of AcroQoL in Korea. <i>BMJ Open.</i> 2015; <b>5</b>(6): e006898–e006898. <a target=xrefwindow id=d39561e4990 href="http://www.ncbi.nlm.nih.gov/pubmed/26063564">PubMed Abstract </a> | <a target=xrefwindow id=d39561e4993 href="https://doi.org/10.1136/bmjopen-2014-006898">Publisher Full Text </a> | <a target=xrefwindow id=d39561e4997 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4466761">Free Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d39561e5006 class=n-a></a>Ghigo E, Biller BMK, Colao A, <i> et al.</i>: Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy. <i>J Endocrinol Invest.</i> 2009; <b>32</b>(11): 924–33. <a target=xrefwindow id=d39561e5017 href="http://www.ncbi.nlm.nih.gov/pubmed/20009494">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5020 href="https://doi.org/10.1007/BF03345774">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d39561e5030 class=n-a></a>Biermasz NR, van den Oever NC, Frolich M, <i> et al.</i>: Sandostatin LAR in acromegaly: A 6-week injection interval suppresses GH secretion as effectively as a 4-week interval. <i>Clin Endocrinol (Oxf).</i> 2003; <b>58</b>(3): 288–95. <a target=xrefwindow id=d39561e5041 href="http://www.ncbi.nlm.nih.gov/pubmed/12608933">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5044 href="https://doi.org/10.1046/j.1365-2265.2003.01710.x">Publisher Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/731932422"><span class="faculty-opinion-icon small"></span></a><a name=d39561e5053 class=n-a></a>Dal J, Klose M, Heck A, <i> et al.</i>: Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: A randomized multicentre study. <i>Eur J Endocrinol.</i> 2018; <b>178</b>(1): 65–74. <a target=xrefwindow id=d39561e5064 href="http://www.ncbi.nlm.nih.gov/pubmed/28993415">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5067 href="https://doi.org/10.1530/EJE-17-0546">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/731932422">Faculty Opinions Recommendation</a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d39561e5080 class=n-a></a>Bronstein MD, Fleseriu M, Neggers S, <i> et al.</i>: Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: Crossover extension to a randomized, double-blind, Phase III study. <i>BMC Endocr Disord.</i> 2016; <b>16</b>: 16. <a target=xrefwindow id=d39561e5091 href="http://www.ncbi.nlm.nih.gov/pubmed/27039081">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5094 href="https://doi.org/10.1186/s12902-016-0096-8">Publisher Full Text </a> | <a target=xrefwindow id=d39561e5098 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4818908">Free Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/2693959"><span class="faculty-opinion-icon small"></span></a><a name=d39561e5107 class=n-a></a>Trainer PJ, Ezzat S, D'Souza GA, <i> et al.</i>: A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly. <i>Clin Endocrinol (Oxf).</i> 2009; <b>71</b>(4): 549–57. <a target=xrefwindow id=d39561e5118 href="http://www.ncbi.nlm.nih.gov/pubmed/19438906">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5121 href="https://doi.org/10.1111/j.1365-2265.2009.03620.x">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/2693959">Faculty Opinions Recommendation</a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d39561e5134 class=n-a></a>Neggers SJCMM, van Aken MO, de Herder WW, <i> et al.</i>: Quality of Life in Acromegalic Patients during Long-Term Somatostatin Analog Treatment with and without Pegvisomant. <i>J Clin Endocrinol Metab.</i> 2008; <b>93</b>(10): 3853–9. <a target=xrefwindow id=d39561e5145 href="http://www.ncbi.nlm.nih.gov/pubmed/18647806">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5148 href="https://doi.org/10.1210/jc.2008-0669">Publisher Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/11971956"><span class="faculty-opinion-icon small"></span></a><a name=d39561e5157 class=n-a></a>Madsen M, Poulsen PL, Orskov H, <i> et al.</i>: Cotreatment with pegvisomant and a somatostatin analog (SA) in SA-responsive acromegalic patients. <i>J Clin Endocrinol Metab.</i> 2011; <b>96</b>(8): 2405–13. <a target=xrefwindow id=d39561e5168 href="http://www.ncbi.nlm.nih.gov/pubmed/21632808">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5171 href="https://doi.org/10.1210/jc.2011-0654">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/11971956">Faculty Opinions Recommendation</a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/717960794"><span class="faculty-opinion-icon small"></span></a><a name=d39561e5185 class=n-a></a>Postma MR, Netea-Maier RT, van den Berg G, <i> et al.</i>: Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. <i>Eur J Endocrinol.</i> 2012; <b>166</b>(4): 585–92. <a target=xrefwindow id=d39561e5196 href="http://www.ncbi.nlm.nih.gov/pubmed/22250074">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5199 href="https://doi.org/10.1530/EJE-11-0853">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/717960794">Faculty Opinions Recommendation</a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d39561e5212 class=n-a></a>Fleseriu M, Molitch M, Dreval A, <i> et al.</i>: Symptom Burden and Impact of Treatment in Patients with Acromegaly Treated with Injectable Somatostatin Receptor Ligands. Poster presentation presented at 18th Congress of the European Neuroendocrine Association; Wrocław, Poland. 2018; 17– 20.</span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d39561e5224 class=n-a></a>Higham CE, Thomas JDJ, Bidlingmaier M, <i> et al.</i>: Successful use of weekly pegvisomant administration in patients with acromegaly. <i>Eur J Endocrinol.</i> 2009; <b>161</b>(1): 21–5. <a target=xrefwindow id=d39561e5235 href="http://www.ncbi.nlm.nih.gov/pubmed/19411301">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5238 href="https://doi.org/10.1530/EJE-08-0990">Publisher Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d39561e5247 class=n-a></a>Giustina A, Arnaldi G, Bogazzi F, <i> et al.</i>: Pegvisomant in acromegaly: An update. <i>J Endocrinol Invest.</i> 2017; <b>40</b>(6): 577–89. <a target=xrefwindow id=d39561e5258 href="http://www.ncbi.nlm.nih.gov/pubmed/28176221">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5261 href="https://doi.org/10.1007/s40618-017-0614-1">Publisher Full Text </a> | <a target=xrefwindow id=d39561e5265 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5443862">Free Full Text </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d39561e5274 class=n-a></a>van der Klaauw AA, Biermasz NR, Hoftijzer HC, <i> et al.</i>: Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. <i>Clin Endocrinol (Oxf).</i> 2008; <b>69</b>(1): 123–8. <a target=xrefwindow id=d39561e5285 href="http://www.ncbi.nlm.nih.gov/pubmed/18182092">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5288 href="https://doi.org/10.1111/j.1365-2265.2007.03169.x">Publisher Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d39561e5297 class=n-a></a>Wexler T, Gunnell L, Omer Z, <i> et al.</i>: Growth Hormone Deficiency Is Associated with Decreased Quality of Life in Patients with Prior Acromegaly. <i>J Clin Endocrinol Metab.</i> 2009; <b>94</b>(7): 2471–7. <a target=xrefwindow id=d39561e5308 href="http://www.ncbi.nlm.nih.gov/pubmed/19366847">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5311 href="https://doi.org/10.1210/jc.2008-2671">Publisher Full Text </a> | <a target=xrefwindow id=d39561e5315 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2708960">Free Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d39561e5325 class=n-a></a>Colao A, Cannavò S, Marzullo P, <i> et al.</i>: Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly. <i>Eur J Endocrinol.</i> 2003; <b>148</b>(1): 31–8. <a target=xrefwindow id=d39561e5336 href="http://www.ncbi.nlm.nih.gov/pubmed/12534355">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5339 href="https://doi.org/10.1530/eje.0.1480031">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d39561e5348 class=n-a></a>Dons RF, Rosselet P, Pastakia B, <i> et al.</i>: Arthropathy in acromegalic patients before and after treatment: A long-term follow-up study. <i>Clin Endocrinol (Oxf).</i> 1988; <b>28</b>(5): 515–24. <a target=xrefwindow id=d39561e5359 href="http://www.ncbi.nlm.nih.gov/pubmed/3265081">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5362 href="https://doi.org/10.1111/j.1365-2265.1988.tb03686.x">Publisher Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736937718"><span class="faculty-opinion-icon small"></span></a><a name=d39561e5371 class=n-a></a>Colao A, Grasso LFS, Di Cera M, <i> et al.</i>: Association between biochemical control and comorbidities in patients with acromegaly: An Italian longitudinal retrospective chart review study. <i>J Endocrinol Invest.</i> 2020; <b>43</b>(4): 529–38. <a target=xrefwindow id=d39561e5382 href="http://www.ncbi.nlm.nih.gov/pubmed/31741320">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5385 href="https://doi.org/10.1007/s40618-019-01138-y ">Publisher Full Text </a> | <a target=xrefwindow id=d39561e5389 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7067716">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736937718">Faculty Opinions Recommendation</a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d39561e5402 class=n-a></a>Claessen KMJA, Ramautar SR, Pereira AM, <i> et al.</i>: Progression of acromegalic arthropathy despite long-term biochemical control: A prospective, radiological study. <i>Eur J Endocrinol.</i> 2012; <b>167</b>(2): 235–44. <a target=xrefwindow id=d39561e5413 href="http://www.ncbi.nlm.nih.gov/pubmed/22645199">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5416 href="https://doi.org/10.1530/EJE-12-0147">Publisher Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d39561e5425 class=n-a></a>Miller A, Doll H, David J, <i> et al.</i>: Impact of musculoskeletal disease on quality of life in long-standing acromegaly. <i>Eur J Endocrinol.</i> 2008; <b>158</b>(5): 587–93. <a target=xrefwindow id=d39561e5436 href="http://www.ncbi.nlm.nih.gov/pubmed/18426816">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5439 href="https://doi.org/10.1530/EJE-07-0838">Publisher Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735639004"><span class="faculty-opinion-icon small"></span></a><a name=d39561e5448 class=n-a></a>Fatti LM, Cangiano B, Vitale G, <i> et al.</i>: Arthropathy in acromegaly: A questionnaire-based estimation of motor disability and its relation with quality of life and work productivity. <i>Pituitary.</i> 2019; <b>22</b>(5): 552–60. <a target=xrefwindow id=d39561e5459 href="http://www.ncbi.nlm.nih.gov/pubmed/31032537">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5462 href="https://doi.org/10.1007/s11102-019-00966-8">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735639004">Faculty Opinions Recommendation</a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/12478956"><span class="faculty-opinion-icon small"></span></a><a name=d39561e5476 class=n-a></a>Wassenaar MJE, Biermasz NR, Hamdy NAT, <i> et al.</i>: High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. <i>Eur J Endocrinol.</i> 2011; <b>164</b>(4): 475–83. <a target=xrefwindow id=d39561e5487 href="http://www.ncbi.nlm.nih.gov/pubmed/21257726">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5490 href="https://doi.org/10.1530/EJE-10-1005">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/12478956">Faculty Opinions Recommendation</a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736065405"><span class="faculty-opinion-icon small"></span></a><a name=d39561e5503 class=n-a></a>Kunzler LS, Naves LA, Casulari LA: The Effect of Cognitive-Behavioral Therapy on Acromegalics After a 9-Month Follow-Up. <i>Front Endocrinol (Lausanne).</i> 2019; <b>10</b>: 380. <a target=xrefwindow id=d39561e5511 href="http://www.ncbi.nlm.nih.gov/pubmed/31244782">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5514 href="https://doi.org/10.3389/fendo.2019.00380">Publisher Full Text </a> | <a target=xrefwindow id=d39561e5517 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6581695">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736065405">Faculty Opinions Recommendation</a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736218623"><span class="faculty-opinion-icon small"></span></a><a name=d39561e5530 class=n-a></a>Lima TRL, Kasuki L, Gadelha M, <i> et al.</i>: Physical exercise improves functional capacity and quality of life in patients with acromegaly: A 12-week follow-up study. <i>Endocrine.</i> 2019; <b>66</b>(2): 301–9. <a target=xrefwindow id=d39561e5541 href="http://www.ncbi.nlm.nih.gov/pubmed/31317523">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5544 href="https://doi.org/10.1007/s12020-019-02011-x">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736218623">Faculty Opinions Recommendation</a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/738325844"><span class="faculty-opinion-icon small"></span></a><a name=d39561e5557 class=n-a></a>Albarel F, Elaraki F, Delemer B: Daily life, needs and expectations of patients with acromegaly in France: An on-line survey. <i>Ann Endocrinol (Paris).</i> 2019; <b>80</b>(2): 110–6. <a target=xrefwindow id=d39561e5565 href="http://www.ncbi.nlm.nih.gov/pubmed/30612694">PubMed Abstract </a> | <a target=xrefwindow id=d39561e5568 href="https://doi.org/10.1016/j.ando.2018.08.006">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/738325844">Faculty Opinions Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Jul 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-791/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-791/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Centre Hospitalier Universitaire de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada<br/> <sup>2</sup> Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health &amp; Science University, 3303 South Bond Avenue, CH8N, Portland, OR, 97239, USA<br/> <p> <div class=margin-bottom> Fabienne Langlois <br/> <span>Roles: </span> Investigation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Gabriela M. Suarez <br/> <span>Roles: </span> Investigation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Maria Fleseriu <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Project Administration, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-791/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 Jul 2020, 9:791 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.22683.1">https://doi.org/10.12688/f1000research.22683.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2020 Langlois F <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=25044 data-id=22683 data-downloads="" data-views="" data-scholar="10.12688/f1000research.22683.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-791/v1/pdf?article_uuid=5fd8c26a-4493-40d7-bedd-874dae87c8da" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.22683.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Langlois F, Suarez GM and Fleseriu M. Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly [version 1; peer review: 3 approved] <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):791 (<a href="https://doi.org/10.12688/f1000research.22683.1" target=_blank>https://doi.org/10.12688/f1000research.22683.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=22683 id=mobile-track-article-signin-22683 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/22683?target=/articles/9-791/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=25044 /> <input name=articleId type=hidden value=22683 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Salvatore Cannavo</strong>, Endocrine Unit, University Hospital G. Martino, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Sebastian J Neggers</strong>, Rotterdam Pituitary Centre, Erasmus University MC, The Netherlands </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Lucio Vilar</strong>, Departamento de Endocrinologia, Hospital de Clínicas, Universidade Federal de Pernambuco (UFPE), Brazil </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Jul 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-791/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-791/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=73144-68283></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=73145-68282></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=73143-68284></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-791/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 Jul 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Salvatore Cannavo</strong>, Endocrine Unit, University Hospital G. Martino, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Sebastian J Neggers</strong>, Rotterdam Pituitary Centre, Erasmus University MC, The Netherlands </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Lucio Vilar</strong>, Departamento de Endocrinologia, Hospital de Clínicas, Universidade Federal de Pernambuco (UFPE), Brazil </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-791/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-791/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Updates in rare and not-so-rare complications...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-791/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-791/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-791/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Langlois F et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-791/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-791",
            templates : {
                twitter : "Updates in rare and not-so-rare complications of acromegaly:.... Langlois F et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-791/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/22683/25044")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "25044");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "68283": 0,
                           "68282": 0,
                           "68284": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "1e1d7d60-c9e8-4305-8d18-bc95478354ac";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-791.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-791.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-791.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-791.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-791.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>